false Q3 0001468328 --12-31 true true true true true true P6Y P11Y P11Y us-gaap:AccruedLiabilitiesCurrent us-gaap:AccruedLiabilitiesCurrent P7Y2M26D P3Y5M1D 0001468328 2020-01-01 2020-09-30 xbrli:shares 0001468328 2020-10-30 iso4217:USD 0001468328 2020-09-30 0001468328 2019-12-31 iso4217:USD xbrli:shares 0001468328 2020-07-01 2020-09-30 0001468328 2019-07-01 2019-09-30 0001468328 2019-01-01 2019-09-30 0001468328 us-gaap:CommonStockMember 2020-06-30 0001468328 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001468328 us-gaap:RetainedEarningsMember 2020-06-30 0001468328 2020-06-30 0001468328 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001468328 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001468328 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001468328 us-gaap:CommonStockMember 2020-09-30 0001468328 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001468328 us-gaap:RetainedEarningsMember 2020-09-30 0001468328 us-gaap:CommonStockMember 2019-12-31 0001468328 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001468328 us-gaap:RetainedEarningsMember 2019-12-31 0001468328 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001468328 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001468328 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001468328 us-gaap:CommonStockMember 2019-06-30 0001468328 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001468328 us-gaap:RetainedEarningsMember 2019-06-30 0001468328 2019-06-30 0001468328 us-gaap:CommonStockMember 2019-07-01 2019-09-30 0001468328 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0001468328 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0001468328 us-gaap:CommonStockMember 2019-09-30 0001468328 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0001468328 us-gaap:RetainedEarningsMember 2019-09-30 0001468328 2019-09-30 0001468328 us-gaap:CommonStockMember 2018-12-31 0001468328 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001468328 us-gaap:RetainedEarningsMember 2018-12-31 0001468328 2018-12-31 0001468328 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0001468328 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-09-30 0001468328 us-gaap:RetainedEarningsMember 2019-01-01 2019-09-30 0001468328 2020-01-01 2020-06-30 0001468328 adus:APlusHealthCareMember 2020-01-01 2020-09-30 0001468328 adus:HospicePartnersMember 2020-01-01 2020-09-30 0001468328 adus:AllianceHomeHealthCareMember 2020-01-01 2020-09-30 0001468328 adus:VIPHealthcareServicesMember 2020-01-01 2020-09-30 adus:segment 0001468328 us-gaap:EmployeeStockOptionMember 2020-09-30 0001468328 us-gaap:EmployeeStockOptionMember 2019-09-30 0001468328 us-gaap:RestrictedStockMember 2020-09-30 0001468328 us-gaap:RestrictedStockMember 2019-09-30 0001468328 us-gaap:EmployeeStockOptionMember 2020-07-01 2020-09-30 0001468328 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-09-30 0001468328 us-gaap:RestrictedStockMember 2020-07-01 2020-09-30 0001468328 us-gaap:RestrictedStockMember 2020-01-01 2020-09-30 0001468328 us-gaap:EmployeeStockOptionMember 2019-07-01 2019-09-30 0001468328 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0001468328 us-gaap:RestrictedStockMember 2019-07-01 2019-09-30 0001468328 us-gaap:RestrictedStockMember 2019-01-01 2019-09-30 0001468328 us-gaap:AccountingStandardsUpdate201613Member 2020-09-30 0001468328 us-gaap:AccountingStandardsUpdate201704Member 2020-09-30 0001468328 us-gaap:AccountingStandardsUpdate201815Member 2020-09-30 0001468328 srt:ScenarioPreviouslyReportedMember 2019-07-01 2019-09-30 0001468328 srt:RestatementAdjustmentMember 2019-07-01 2019-09-30 0001468328 srt:ScenarioPreviouslyReportedMember 2019-01-01 2019-09-30 0001468328 srt:RestatementAdjustmentMember 2019-01-01 2019-09-30 0001468328 srt:MinimumMember 2020-01-01 2020-09-30 0001468328 srt:MaximumMember 2020-01-01 2020-09-30 0001468328 adus:FriscoCorporateHeadquarterMember 2020-07-01 2020-09-30 0001468328 adus:FriscoCorporateHeadquarterMember 2020-01-01 2020-09-30 utr:sqft xbrli:pure 0001468328 adus:APlusHealthCareMember 2020-07-01 2020-07-01 0001468328 adus:APlusHealthCareMember 2020-07-01 2020-09-30 0001468328 adus:APlusHealthCareMember 2020-07-01 0001468328 adus:APlusHealthCareMember us-gaap:TradeNamesMember 2020-07-01 2020-07-01 0001468328 adus:HospicePartnersMember 2019-10-01 2019-10-01 0001468328 adus:HospicePartnersMember us-gaap:CommonStockMember 2019-10-01 2019-10-01 0001468328 adus:HospicePartnersMember us-gaap:CommonStockMember 2019-10-01 0001468328 adus:HospicePartnersMember us-gaap:CommonStockMember us-gaap:OverAllotmentOptionMember 2019-10-01 2019-10-01 adus:location 0001468328 adus:HospicePartnersMember 2019-10-01 0001468328 adus:HospicePartnersMember us-gaap:TradeNamesMember 2019-10-01 2019-10-01 0001468328 adus:HospicePartnersMember us-gaap:NoncompeteAgreementsMember 2019-10-01 2019-10-01 0001468328 adus:HospicePartnersMember us-gaap:NoncompeteAgreementsMember srt:MinimumMember 2019-10-01 2019-10-01 0001468328 adus:HospicePartnersMember us-gaap:NoncompeteAgreementsMember srt:MaximumMember 2019-10-01 2019-10-01 0001468328 adus:HospicePartnersMember adus:StateLicensesMember 2019-10-01 2019-10-01 0001468328 adus:HospicePartnersMember 2020-07-01 2020-09-30 0001468328 adus:AllianceHomeHealthCareMember 2019-08-01 2019-08-01 0001468328 adus:AllianceHomeHealthCareMember 2019-07-01 2019-09-30 0001468328 adus:AllianceHomeHealthCareMember 2019-01-01 2019-09-30 0001468328 adus:AllianceHomeHealthCareMember 2019-08-01 0001468328 adus:AllianceHomeHealthCareMember adus:StateLicensesMember 2019-08-01 2019-08-01 0001468328 adus:AllianceHomeHealthCareMember stpr:NY 2020-07-01 2020-09-30 0001468328 adus:AllianceHomeHealthCareMember stpr:NY 2019-07-01 2019-09-30 0001468328 adus:AllianceHomeHealthCareMember stpr:NY 2020-01-01 2020-09-30 0001468328 adus:AllianceHomeHealthCareMember stpr:NY 2019-01-01 2019-09-30 0001468328 adus:VIPHealthcareServicesMember 2019-06-01 2019-06-01 0001468328 adus:VIPHealthcareServicesMember 2019-01-01 2019-09-30 0001468328 adus:VIPHealthcareServicesMember 2019-07-01 2019-09-30 0001468328 adus:VIPHealthcareServicesMember 2019-06-01 0001468328 adus:VIPHealthcareServicesMember adus:StateLicensesMember 2019-06-01 2019-06-01 0001468328 adus:VIPHealthcareServicesMember us-gaap:CustomerRelationshipsMember 2019-06-01 2019-06-01 0001468328 adus:VIPHealthcareServicesMember stpr:NY 2020-07-01 2020-09-30 0001468328 adus:VIPHealthcareServicesMember stpr:NY 2019-07-01 2019-09-30 0001468328 adus:VIPHealthcareServicesMember stpr:NY 2020-01-01 2020-09-30 0001468328 adus:VIPHealthcareServicesMember stpr:NY 2019-01-01 2019-09-30 0001468328 adus:PersonalCareMember 2019-12-31 0001468328 adus:HospiceMember 2019-12-31 0001468328 adus:HomeHealthMember 2019-12-31 0001468328 adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 adus:HospiceMember 2020-01-01 2020-09-30 0001468328 adus:HomeHealthMember 2020-01-01 2020-09-30 0001468328 adus:PersonalCareMember 2020-09-30 0001468328 adus:HospiceMember 2020-09-30 0001468328 adus:HomeHealthMember 2020-09-30 0001468328 srt:MinimumMember us-gaap:CustomerRelationshipsMember 2020-01-01 2020-09-30 0001468328 us-gaap:CustomerRelationshipsMember srt:MaximumMember 2020-01-01 2020-09-30 0001468328 adus:APlusHealthCareMember adus:PersonalCareMember 2020-09-30 0001468328 us-gaap:GeneralAndAdministrativeExpenseMember 2020-07-01 2020-09-30 0001468328 us-gaap:GeneralAndAdministrativeExpenseMember 2020-01-01 2020-09-30 0001468328 adus:StateLicensesMember 2020-09-30 0001468328 us-gaap:CustomerRelationshipsMember 2020-09-30 0001468328 us-gaap:TrademarksAndTradeNamesMember 2020-09-30 0001468328 us-gaap:NoncompeteAgreementsMember 2020-09-30 0001468328 us-gaap:TradeNamesMember 2019-01-01 2019-09-30 0001468328 adus:CoronavirusAidReliefAndEconomicSecurityActMember 2020-09-30 0001468328 adus:SeniorSecuredCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2020-09-30 0001468328 adus:SeniorSecuredCreditFacilityMember us-gaap:RevolvingCreditFacilityMember 2019-12-31 0001468328 adus:SeniorSecuredCreditFacilityMember adus:TermLoanMember 2020-09-30 0001468328 adus:SeniorSecuredCreditFacilityMember adus:TermLoanMember 2019-12-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember 2018-10-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember us-gaap:RevolvingCreditFacilityMember 2018-10-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember adus:DelayedDrawTermLoanMember 2018-10-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember 2018-10-31 2018-10-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember adus:BasedOnApplicableSeniorLeverageRatioMember srt:MinimumMember 2018-10-31 2018-10-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember adus:BasedOnApplicableSeniorLeverageRatioMember srt:MaximumMember 2018-10-31 2018-10-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember adus:FederalFundsRateMember 2018-10-31 2018-10-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember us-gaap:LondonInterbankOfferedRateLIBORMember srt:MinimumMember 2018-10-31 2018-10-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember us-gaap:LondonInterbankOfferedRateLIBORMember 2018-10-31 2018-10-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember adus:BasedOnApplicableLeverageRatioMember srt:MinimumMember 2018-10-31 2018-10-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember adus:BasedOnApplicableLeverageRatioMember srt:MaximumMember 2018-10-31 2018-10-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember srt:MaximumMember 2018-10-31 2018-10-31 0001468328 adus:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember adus:CapitalOneMember 2019-09-12 2019-09-12 0001468328 adus:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember adus:CapitalOneMember 2019-09-12 0001468328 adus:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember adus:CapitalOneMember srt:MinimumMember 2019-09-12 2019-09-12 0001468328 adus:CreditAgreementMember us-gaap:RevolvingCreditFacilityMember adus:CapitalOneMember srt:MaximumMember 2019-09-12 2019-09-12 0001468328 adus:RestrictionOnDividendsMember adus:CreditAgreementMember srt:MaximumMember adus:CapitalOneMember 2019-09-12 2019-09-12 0001468328 adus:CreditAgreementMember adus:CapitalOneMember us-gaap:RevolvingCreditFacilityMember 2020-01-01 2020-09-30 0001468328 adus:CreditAgreementMember adus:CapitalOneMember us-gaap:RevolvingCreditFacilityMember 2020-09-30 0001468328 adus:CreditAgreementMember adus:CapitalOneMember adus:TermLoanMember 2020-09-30 0001468328 adus:CreditAgreementMember adus:CapitalOneMember 2020-09-30 0001468328 adus:CreditAgreementMember adus:CapitalOneMember us-gaap:RevolvingCreditFacilityMember 2019-12-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember adus:TermLoanMember 2019-12-31 0001468328 adus:CreditAgreementMember adus:CapitalOneMember 2019-12-31 0001468328 adus:PaycheckProtectionProgramAndHealthCareEnhancementActMember 2020-04-24 2020-04-24 0001468328 adus:PaycheckProtectionProgramAndHealthCareEnhancementActMember 2020-04-01 2020-04-30 0001468328 adus:PaycheckProtectionProgramAndHealthCareEnhancementActMember 2020-09-30 0001468328 adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 adus:HospiceMember 2020-07-01 2020-09-30 0001468328 adus:HomeHealthMember 2020-07-01 2020-09-30 0001468328 us-gaap:OperatingSegmentsMember adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:OperatingSegmentsMember adus:HospiceMember 2020-07-01 2020-09-30 0001468328 us-gaap:OperatingSegmentsMember adus:HomeHealthMember 2020-07-01 2020-09-30 0001468328 us-gaap:OperatingSegmentsMember 2020-07-01 2020-09-30 0001468328 adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 adus:HospiceMember 2019-07-01 2019-09-30 0001468328 adus:HomeHealthMember 2019-07-01 2019-09-30 0001468328 adus:PersonalCareMember us-gaap:OperatingSegmentsMember 2019-07-01 2019-09-30 0001468328 adus:HospiceMember us-gaap:OperatingSegmentsMember 2019-07-01 2019-09-30 0001468328 adus:HomeHealthMember us-gaap:OperatingSegmentsMember 2019-07-01 2019-09-30 0001468328 us-gaap:OperatingSegmentsMember 2019-07-01 2019-09-30 0001468328 us-gaap:OperatingSegmentsMember adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:OperatingSegmentsMember adus:HospiceMember 2020-01-01 2020-09-30 0001468328 us-gaap:OperatingSegmentsMember adus:HomeHealthMember 2020-01-01 2020-09-30 0001468328 us-gaap:OperatingSegmentsMember 2020-01-01 2020-09-30 0001468328 adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 adus:HospiceMember 2019-01-01 2019-09-30 0001468328 adus:HomeHealthMember 2019-01-01 2019-09-30 0001468328 us-gaap:OperatingSegmentsMember adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 us-gaap:OperatingSegmentsMember adus:HospiceMember 2019-01-01 2019-09-30 0001468328 us-gaap:OperatingSegmentsMember adus:HomeHealthMember 2019-01-01 2019-09-30 0001468328 us-gaap:OperatingSegmentsMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:StateLocalAndOtherGovernmentalProgramsMember adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:PrivatePayMember adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:CommercialInsuranceMember adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:StateLocalAndOtherGovernmentalProgramsMember adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:PrivatePayMember adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:CommercialInsuranceMember adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:StateLocalAndOtherGovernmentalProgramsMember adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:PrivatePayMember adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:CommercialInsuranceMember adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:StateLocalAndOtherGovernmentalProgramsMember adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:PrivatePayMember adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:CommercialInsuranceMember adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:MedicareMember 2020-07-01 2020-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember 2020-07-01 2020-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember 2020-07-01 2020-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:MedicareMember 2019-07-01 2019-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember 2019-07-01 2019-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember 2019-07-01 2019-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:MedicareMember 2020-01-01 2020-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember 2020-01-01 2020-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember 2020-01-01 2020-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:MedicareMember 2019-01-01 2019-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember 2019-01-01 2019-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember 2019-01-01 2019-09-30 0001468328 adus:HospiceMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:MedicareMember 2020-07-01 2020-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember 2020-07-01 2020-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember 2020-07-01 2020-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-07-01 2020-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:MedicareMember 2019-07-01 2019-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember 2019-07-01 2019-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember 2019-07-01 2019-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-07-01 2019-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:MedicareMember 2020-01-01 2020-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember 2020-01-01 2020-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember 2020-01-01 2020-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:MedicareMember 2019-01-01 2019-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:ManagedCareOrganizationsMember 2019-01-01 2019-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember adus:OtherMember 2019-01-01 2019-09-30 0001468328 adus:HomeHealthMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:IL adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NY adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:AllOtherStatesMember adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:PersonalCareMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:IL adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NY adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:AllOtherStatesMember adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:PersonalCareMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:IL adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NY adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:AllOtherStatesMember adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:PersonalCareMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:IL adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NY adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:AllOtherStatesMember adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:PersonalCareMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:HospiceMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:AllOtherStatesMember adus:HospiceMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:HospiceMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:HospiceMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:HospiceMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:HospiceMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:AllOtherStatesMember adus:HospiceMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:HospiceMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:HospiceMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:HospiceMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:HomeHealthMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:HomeHealthMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:HomeHealthMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:HomeHealthMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:HomeHealthMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:HomeHealthMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:NM adus:HomeHealthMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember adus:HomeHealthMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember adus:IllinoisDepartmentOnAgingMember 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember adus:IllinoisDepartmentOnAgingMember 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember adus:IllinoisDepartmentOnAgingMember 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember adus:IllinoisDepartmentOnAgingMember 2019-01-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:IL 2020-07-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:IL 2019-07-01 2019-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:IL 2020-01-01 2020-09-30 0001468328 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember stpr:IL 2019-01-01 2019-09-30 0001468328 us-gaap:AccountsReceivableMember adus:IllinoisDepartmentOnAgingMember 2020-01-01 2020-09-30 0001468328 us-gaap:AccountsReceivableMember adus:IllinoisDepartmentOnAgingMember 2019-01-01 2019-12-31 0001468328 us-gaap:SubsequentEventMember adus:CountyHomeMakersIncorporatedMember 2020-10-31 2020-11-01

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2020

OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-34504

ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)

Delaware |  | 20-5340172
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
6303 Cowboys Way, Suite 600 Frisco, TX |  | 75034
(Address of principal executive offices) |  | (Zip Code)

(469) 535-8200

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, $0.001 par value | ADUS | The Nasdaq Global Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐.

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer |  | ☒ |  | Accelerated Filer |  | ☐
Non-Accelerated Filer |  | ☐ |  | Smaller Reporting Company |  | ☐
Emerging Growth Company |  | ☐ |  |  |  |

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒.

As of October 30, 2020, Addus HomeCare Corporation had 15,808,708 shares of Common Stock outstanding.

Table of Contents

ADDUS HOMECARE CORPORATION

FORM 10-Q

INDEX

PART I. FINANCIAL INFORMATION | 3
Item 1. Financial Statements (Unaudited) | 3
Condensed Consolidated Balance Sheets as of September 30, 2020 and December 31, 2019 | 3
Condensed Consolidated Statements of Income For the Three and Nine Months Ended September 30, 2020 and 2019 | 4
Condensed Consolidated Statement of Stockholders’ Equity For the Three and Nine Months Ended September 30, 2020 and 2019 | 5
Condensed Consolidated Statements of Cash Flows For the Nine Months Ended September 30, 2020 and 2019 | 7
Notes to Condensed Consolidated Financial Statements | 8
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 22
Item 3. Quantitative and Qualitative Disclosures About Market Risk | 37
Item 4. Controls and Procedures | 37
PART II. OTHER INFORMATION | 38
Item 1. Legal Proceedings | 38
Item 1A. Risk Factors | 38
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 38
Item 3. Defaults Upon Senior Securities | 38
Item 4. Mine Safety Disclosures | 38
Item 5. Other Information | 38
Item 6. Exhibits | 39

2

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. | Financial Statements

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

As of September 30, 2020 and December 31, 2019

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)

|  | September 30, 2020 |  |  | December 31, 2019 |
Assets |  |  |  |  |  |  |  |
Current assets |  |  |  |  |  |  |  |
Cash |  | $ | 170,331 |  |  | $ | 111,714 |
Accounts receivable, net |  |  | 118,623 |  |  |  | 149,680 |
Prepaid expenses and other current assets |  |  | 10,426 |  |  |  | 7,993 |
Total current assets |  |  | 299,380 |  |  |  | 269,387 |
Property and equipment, net of accumulated depreciation and amortization |  |  | 19,305 |  |  |  | 12,156 |
Other assets |  |  |  |  |  |  |  |
Goodwill |  |  | 286,552 |  |  |  | 275,368 |
Intangibles, net of accumulated amortization |  |  | 52,873 |  |  |  | 57,079 |
Deferred tax assets, net |  |  | 1,479 |  |  |  | 1,647 |
Operating lease assets, net |  |  | 35,842 |  |  |  | 21,111 |
Total other assets |  |  | 376,746 |  |  |  | 355,205 |
Total assets |  | $ | 695,431 |  |  | $ | 636,748 |
Liabilities and stockholders' equity |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |
Accounts payable |  | $ | 17,270 |  |  | $ | 19,641 |
Accrued payroll |  |  | 26,315 |  |  |  | 30,587 |
Accrued expenses |  |  | 33,395 |  |  |  | 22,429 |
Accrued workers' compensation insurance |  |  | 14,668 |  |  |  | 14,143 |
Current portion of long-term debt |  |  | 2,095 |  |  |  | 728 |
Total current liabilities |  |  | 93,743 |  |  |  | 87,528 |
Long-term liabilities |  |  |  |  |  |  |  |
Long-term debt, less current portion, net of debt issuance costs |  |  | 59,561 |  |  |  | 59,164 |
Long-term operating lease liabilities |  |  | 33,977 |  |  |  | 14,301 |
Other long-term liabilities |  |  | 550 |  |  |  | 163 |
Total long-term liabilities |  |  | 94,088 |  |  |  | 73,628 |
Total liabilities |  | $ | 187,831 |  |  | $ | 161,156 |
Stockholders' equity |  |  |  |  |  |  |  |
Common stock—$.001 par value; 40,000 authorized and 15,801 and 15,617 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively |  | $ | 16 |  |  | $ | 15 |
Additional paid-in capital |  |  | 366,868 |  |  |  | 359,545 |
Retained earnings |  |  | 140,716 |  |  |  | 116,032 |
Total stockholders' equity |  |  | 507,600 |  |  |  | 475,592 |
Total liabilities and stockholders' equity |  | $ | 695,431 |  |  | $ | 636,748 |

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

3

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

For the Three and Nine Months Ended September 30, 2020 and 2019

(Amounts and Shares in Thousands, Except Per Share Data)

(Unaudited)

|  | For the Three Months Ended September 30, |  |  | For the Nine Months Ended September 30, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Net service revenues |  | $ | 193,987 |  |  | $ | 168,993 |  |  | $ | 568,779 |  |  | $ | 456,415 |
Cost of service revenues |  |  | 137,686 |  |  |  | 123,817 |  |  |  | 401,646 |  |  |  | 334,719 |
Gross profit |  |  | 56,301 |  |  |  | 45,176 |  |  |  | 167,133 |  |  |  | 121,696 |
General and administrative expenses |  |  | 40,733 |  |  |  | 35,085 |  |  |  | 125,470 |  |  |  | 94,109 |
Depreciation and amortization |  |  | 3,045 |  |  |  | 2,756 |  |  |  | 8,872 |  |  |  | 7,365 |
Total operating expenses |  |  | 43,778 |  |  |  | 37,841 |  |  |  | 134,342 |  |  |  | 101,474 |
Operating income from continuing operations |  |  | 12,523 |  |  |  | 7,335 |  |  |  | 32,791 |  |  |  | 20,222 |
Interest income |  |  | (87 | ) |  |  | (786 | ) |  |  | (576 | ) |  |  | (1,096 | )
Interest expense |  |  | 680 |  |  |  | 866 |  |  |  | 2,309 |  |  |  | 2,164 |
Total interest expense, net |  |  | 593 |  |  |  | 80 |  |  |  | 1,733 |  |  |  | 1,068 |
Income from continuing operations before income taxes |  |  | 11,930 |  |  |  | 7,255 |  |  |  | 31,058 |  |  |  | 19,154 |
Income tax expense |  |  | 2,811 |  |  |  | 1,769 |  |  |  | 6,374 |  |  |  | 4,080 |
Net income from continuing operations |  |  | 9,119 |  |  |  | 5,486 |  |  |  | 24,684 |  |  |  | 15,074 |
Net loss from discontinued operations |  |  | — |  |  |  | (574 | ) |  |  | — |  |  |  | (574 | )
Net income |  | $ | 9,119 |  |  | $ | 4,912 |  |  | $ | 24,684 |  |  | $ | 14,500 |
Net income per common share |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic income per share |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | 0.58 |  |  | $ | 0.40 |  |  | $ | 1.59 |  |  | $ | 1.14 |
Discontinued operations |  |  | — |  |  |  | (0.04 | ) |  |  | — |  |  |  | (0.04 | )
Basic income per share |  | $ | 0.58 |  |  | $ | 0.36 |  |  | $ | 1.59 |  |  | $ | 1.10 |
Diluted income per share |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Continuing operations |  | $ | 0.57 |  |  | $ | 0.39 |  |  | $ | 1.55 |  |  | $ | 1.10 |
Discontinued operations |  |  | — |  |  |  | (0.04 | ) |  |  | — |  |  |  | (0.04 | )
Diluted income per share |  | $ | 0.57 |  |  | $ | 0.35 |  |  | $ | 1.55 |  |  | $ | 1.06 |
Weighted average number of common shares and potential common shares outstanding: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 15,618 |  |  |  | 13,766 |  |  |  | 15,573 |  |  |  | 13,271 |
Diluted |  |  | 15,957 |  |  |  | 14,203 |  |  |  | 15,934 |  |  |  | 13,687 |

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

4

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the Three and Nine Months Ended September 30, 2020

(Amounts and Shares in Thousands)

(Unaudited)

|  | For the Three Months Ended September 30, 2020 |
|  | Common Stock |  |  | Additional Paid-in Capital |  |  | Retained Earnings |  |  | Total Stockholders’ Equity |
|  | Shares |  |  | Amount |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at July 1, 2020 |  |  | 15,665 |  |  | $ | 16 |  |  | $ | 363,248 |  |  | $ | 131,597 |  |  | $ | 494,861 |
Issuance of shares of common stock under restricted stock award agreements |  |  | 81 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Stock-based compensation |  |  | — |  |  |  | — |  |  |  | 1,462 |  |  |  | — |  |  |  | 1,462 |
Shares issued for exercise of stock options |  |  | 55 |  |  |  | — |  |  |  | 2,158 |  |  |  | — |  |  |  | 2,158 |
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 9,119 |  |  |  | 9,119 |
Balance at September 30, 2020 |  |  | 15,801 |  |  | $ | 16 |  |  | $ | 366,868 |  |  | $ | 140,716 |  |  | $ | 507,600 |
|  | For the Nine Months Ended September 30, 2020 |
|  | Common Stock |  |  | Additional Paid-in Capital |  |  | Retained Earnings |  |  | Total Stockholders' Equity |
Balance at January 1, 2020 |  |  | 15,617 |  |  | $ | 15 |  |  | $ | 359,545 |  |  | $ | 116,032 |  |  | $ | 475,592 |
Issuance of shares of common stock under restricted stock award agreements |  |  | 81 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeiture of shares of common stock under restricted stock award agreements |  |  | (6 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Stock-based compensation |  |  | — |  |  |  | — |  |  |  | 3,987 |  |  |  | — |  |  |  | 3,987 |
Shares issued for exercise of stock options |  |  | 109 |  |  |  | 1 |  |  |  | 3,336 |  |  |  | — |  |  |  | 3,337 |
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 24,684 |  |  |  | 24,684 |
Balance at September 30, 2020 |  |  | 15,801 |  |  | $ | 16 |  |  | $ | 366,868 |  |  | $ | 140,716 |  |  | $ | 507,600 |

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

5

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

For the Three and Nine Months Ended September 30, 2019

(Amounts and Shares in Thousands)

(Unaudited)

|  | For the Three Months Ended September 30, 2019 |
|  | Common Stock |  |  | Additional Paid-in Capital |  |  | Retained Earnings |  |  | Total Stockholders' Equity |
Balance at July 1, 2019 |  |  | 13,219 |  |  | $ | 13 |  |  | $ | 181,111 |  |  | $ | 100,383 |  |  | $ | 281,507 |
Issuance of shares of common stock under restricted stock award agreements |  |  | 1 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeiture of shares of common stock under restricted stock award agreements |  |  | (4 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Stock-based compensation |  |  | — |  |  |  | — |  |  |  | 1,470 |  |  |  | — |  |  |  | 1,470 |
Shares issued for exercise of stock options |  |  | 43 |  |  |  | — |  |  |  | 1,365 |  |  |  | — |  |  |  | 1,365 |
Shares issued in Public Offering, net of offering costs |  |  | 2,300 |  |  |  | 2 |  |  |  | 172,943 |  |  |  | — |  |  |  | 172,945 |
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 4,912 |  |  |  | 4,912 |
Balance at September 30, 2019 |  |  | 15,559 |  |  | $ | 15 |  |  | $ | 356,889 |  |  | $ | 105,295 |  |  | $ | 462,199 |
|  | For the Nine Months Ended September 30, 2019 |
|  | Common Stock |  |  | Additional Paid-in Capital |  |  | Retained Earnings |  |  | Total Stockholders' Equity |
Balance at January 1, 2019 |  |  | 13,126 |  |  | $ | 13 |  |  | $ | 177,683 |  |  | $ | 90,795 |  |  | $ | 268,491 |
Issuance of shares of common stock under restricted stock award agreements |  |  | 64 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Forfeiture of shares of common stock under restricted stock award agreements |  |  | (4 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Stock-based compensation |  |  | — |  |  |  | — |  |  |  | 4,186 |  |  |  | — |  |  |  | 4,186 |
Shares issued for exercise of stock options |  |  | 73 |  |  |  | — |  |  |  | 2,077 |  |  |  | — |  |  |  | 2,077 |
Shares issued in Public Offering, net of offering costs |  |  | 2,300 |  |  |  | 2 |  |  |  | 172,943 |  |  |  | — |  |  |  | 172,945 |
Net income |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 14,500 |  |  |  | 14,500 |
Balance at September 30, 2019 |  |  | 15,559 |  |  | $ | 15 |  |  | $ | 356,889 |  |  | $ | 105,295 |  |  | $ | 462,199 |

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

6

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the Nine Months Ended September 30, 2020 and 2019

(Amounts in Thousands)

(Unaudited)

|  | For the Nine Months |
|  | Ended September 30, |
|  | 2020 |  |  | 2019 |
Cash flows from operating activities: |  |  |  |  |  |  |  |
Net income |  | $ | 24,684 |  |  | $ | 14,500 |
Adjustments to reconcile net income to net cash provided by operating activities, net of acquisitions: |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 8,872 |  |  |  | 7,365 |
Deferred income taxes |  |  | 51 |  |  |  | 105 |
Stock-based compensation |  |  | 3,987 |  |  |  | 4,186 |
Amortization of debt issuance costs under the credit facility |  |  | 554 |  |  |  | 533 |
Provision for doubtful accounts |  |  | 681 |  |  |  | 168 |
Loss (gain) of disposal of assets and asset impairment |  |  | 1,242 |  |  |  | (90 | )
Changes in operating assets and liabilities, net of acquisitions: |  |  |  |  |  |  |  |
Accounts receivable |  |  | 30,746 |  |  |  | (19,957 | )
Prepaid expenses and other current assets |  |  | (2,592 | ) |  |  | 2,822 |
Accounts payable |  |  | (2,496 | ) |  |  | 1,856 |
Accrued expenses and other long-term liabilities |  |  | 7,570 |  |  |  | (3,404 | )
Net cash provided by operating activities |  |  | 73,299 |  |  |  | 8,084 |
Cash flows from investing activities: |  |  |  |  |  |  |  |
Purchases of property and equipment |  |  | (5,893 | ) |  |  | (3,077 | )
Acquisitions of businesses, net of cash acquired |  |  | (11,869 | ) |  |  | (53,224 | )
Proceeds from disposal of assets |  |  | 255 |  |  |  | — |
Net cash used in investing activities |  |  | (17,507 | ) |  |  | (56,301 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |
Proceeds from issuance of common stock, net of offering costs |  |  | — |  |  |  | 172,945 |
Borrowings on revolver — credit facility |  |  | — |  |  |  | 23,458 |
Borrowings on term loan — credit facility |  |  | — |  |  |  | 19,600 |
Payments on term loan — credit facility |  |  | (490 | ) |  |  | (245 | )
Payments for debt issuance costs under the credit facility |  |  | — |  |  |  | (361 | )
Payments on financing lease obligations |  |  | (22 | ) |  |  | (54 | )
Cash received from exercise of stock options |  |  | 3,337 |  |  |  | 2,077 |
Net cash provided by financing activities |  |  | 2,825 |  |  |  | 217,420 |
Net change in cash |  |  | 58,617 |  |  |  | 169,203 |
Cash, at beginning of period |  |  | 111,714 |  |  |  | 70,406 |
Cash, at end of period |  | $ | 170,331 |  |  | $ | 239,609 |
Supplemental disclosures of cash flow information: |  |  |  |  |  |  |  |
Cash paid for interest |  | $ | 1,869 |  |  | $ | 1,594 |
Cash paid for income taxes |  |  | 9,119 |  |  |  | 5,808 |
Supplemental disclosures of non-cash investing and financing activities: |  |  |  |  |  |  |  |
Leasehold improvements acquired through tenant allowances |  | $ | 4,871 |  |  | $ | 682 |

See accompanying Notes to Condensed Consolidated Financial Statements (Unaudited)

7

Table of Contents

ADDUS HOMECARE CORPORATION

AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. Nature of Operations, Consolidation, and Presentation of Financial Statements

Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company”, “we”, “us” or “our”) operate as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care services segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy. The Company’s payors include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals.

Basis of Presentation

The accompanying Unaudited Condensed Consolidated Financial Statements and related notes have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q. The accompanying balance sheet as of December 31, 2019 has been derived from the Company’s audited financial statements for the year ended December 31, 2019 previously filed with the SEC. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America (“GAAP”) for annual financial statements and should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, 2019 included in our Annual Report on Form 10-K, which includes information and disclosures not included herein.

In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

Principles of Consolidation

These Unaudited Condensed Consolidated Financial Statements include the accounts of Addus HomeCare Corporation, and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

2. Summary of Significant Accounting Policies

Estimates

The financial statements are prepared by management in conformity with GAAP and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include revenue recognition, accounts receivable and allowances and goodwill and intangible assets. Actual results could differ from those estimates.

Diluted Net Income Per Common Share

Diluted net income per common share, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The Company’s outstanding securities that may potentially dilute the common stock are stock options and restricted stock awards.

As of September 30, 2020 and 2019, dilutive stock options outstanding were approximately 523,000 and 650,000, respectively, and dilutive restricted stock awards outstanding were approximately 149,000 and 147,000, respectively.

Included in the Company’s calculation of diluted earnings per share for the three and nine months ended September 30, 2020, dilutive stock options outstanding were approximately 301,000 and 303,000, respectively. In addition, dilutive restricted stock awards outstanding were approximately 38,000 and 58,000 for the three and nine months ended September 30, 2020, respectively.

Included in the Company’s calculation of diluted earnings per share for the three and nine months ended September 30, 2019, were approximately 359,000 and 335,000 dilutive stock options outstanding, respectively. In addition, dilutive restricted stock awards outstanding were approximately 78,000 and 81,000 for the three and nine months ended September 30, 2019, respectively.

8

Table of Contents

Recently Adopted Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. We have reviewed our provision for doubtful accounts process as required by ASU 2016-13. Management estimates allowances on accounts receivable based upon historical experience and other factors, including an aging of accounts receivable, evaluation of expected adjustments, past adjustments and collection experience in relation to amounts billed, current contract and reimbursement terms, shifts in payors and other current relevant information. The Company recorded a provision for doubtful accounts of $0.2 million and $0.7 million for the three and nine months ended September 30, 2020, respectively. Allowance for doubtful accounts was $0.8 million and $1.0 million as of September 30, 2020 and December 31, 2019, respectively. Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The new guidance eliminates the requirement to calculate the implied fair value of goodwill (i.e., Step 2 of the current goodwill impairment test) to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value (i.e., measure the charge based on the current Step 1). Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

In August 2018, the FASB issued ASU 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. ASU 2018-15 requires customers in a hosting arrangement that is a service contract to follow the internal-use software guidance in Accounting Standards Codification (“ASC”) 350-40 to determine which implementation costs to capitalize as assets or expense as incurred. Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

Recently Issued Accounting Pronouncements

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 intends to simplify various aspects related to accounting for income taxes and removes certain exceptions to the general guidance in ASC 740. In addition, the ASU clarifies and amends existing guidance to improve consistent application of its requirements. The ASU is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. Adoption of the new standard is not expected to have an impact on our results of operations or liquidity.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, and other transactions subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. Therefore, it will be in effect for a limited time through December 31, 2022. The ASU can be adopted no later than December 1, 2022 with early adoption permitted. The Company is evaluating the effect of adopting this new accounting guidance.

3. Revision of Previously Issued Financial Statements

In connection with management finalizing their financial reporting close process for the year ended December 31, 2019, management identified certain immaterial errors impacting the current period and previous periods dating back to periods prior to 2017, including interim periods within those years. Specifically, management determined there were certain errors in the information utilized to accurately estimate the implicit price concessions necessary to reduce net service revenues to the amount expected to be collected. Accordingly, management determined that our accounts receivable allowance was understated. The correction reflects the impact on the Company’s income tax provision and related accounts as a result of correcting for the error as discussed above. Additionally, the Company identified and corrected other immaterial unrelated income tax items impacting deferred tax assets and other immaterial items.

Management evaluated the impact of the errors on all previously issued financial statements and concluded such previously issued financial statements were not materially misstated; however, to reflect such corrections in the quarter ended December 31, 2019 financial statements would materially misstate the 2019 fiscal year. Accordingly, management revised previously issued financial statements to correct for the impact of the errors. The Company’s consolidated financial statements have been revised from the amounts previously reported to correct these immaterial errors as shown in the tables below and are reflected throughout the financial statements and related notes, as applicable.

9

Table of Contents

The Consolidated Statements of Income has been revised to reflect the correction for the three and nine months ended September 30, 2019 as follows (amounts in thousands, except per share data):

|  | For the Three Months Ended September 30, |  |  | For the Nine Months Ended September 30, |
|  | 2019 |  |  | 2019 |
|  | As |  |  |  |  |  |  |  |  |  |  | As |  |  |  |  |  |  |  |  |
|  | Previously |  |  |  |  |  |  | As |  |  | Previously |  |  |  |  |  |  | As |
|  | Reported |  |  | Revision |  |  | Revised |  |  | Reported |  |  | Revision |  |  | Revised |
Net service revenues |  | $ | 169,803 |  |  | $ | (810 | ) |  | $ | 168,993 |  |  | $ | 458,749 |  |  | $ | (2,334 | ) |  | $ | 456,415 |
Gross profit |  |  | 45,986 |  |  |  | (810 | ) |  |  | 45,176 |  |  |  | 124,030 |  |  |  | (2,334 | ) |  |  | 121,696 |
General and administrative expenses |  |  | 35,950 |  |  |  | (865 | ) |  |  | 35,085 |  |  |  | 95,429 |  |  |  | (1,320 | ) |  |  | 94,109 |
Total operating expenses |  |  | 38,706 |  |  |  | (865 | ) |  |  | 37,841 |  |  |  | 102,794 |  |  |  | (1,320 | ) |  |  | 101,474 |
Operating income from continuing operations |  |  | 7,280 |  |  |  | 55 |  |  |  | 7,335 |  |  |  | 21,236 |  |  |  | (1,014 | ) |  |  | 20,222 |
Income from continuing operations before income taxes |  |  | 7,200 |  |  |  | 55 |  |  |  | 7,255 |  |  |  | 20,168 |  |  |  | (1,014 | ) |  |  | 19,154 |
Income tax expense |  |  | 1,759 |  |  |  | 10 |  |  |  | 1,769 |  |  |  | 4,347 |  |  |  | (267 | ) |  |  | 4,080 |
Net income from continuing operations |  |  | 5,441 |  |  |  | 45 |  |  |  | 5,486 |  |  |  | 15,821 |  |  |  | (747 | ) |  |  | 15,074 |
Net income |  | $ | 4,867 |  |  | $ | 45 |  |  | $ | 4,912 |  |  | $ | 15,247 |  |  | $ | (747 | ) |  | $ | 14,500 |
Basic income per share |  | $ | 0.36 |  |  | $ | — |  |  | $ | 0.36 |  |  | $ | 1.15 |  |  | $ | (0.05 | ) |  | $ | 1.10 |
Diluted income per share |  | $ | 0.34 |  |  | $ | 0.01 |  |  | $ | 0.35 |  |  | $ | 1.12 |  |  | $ | (0.06 | ) |  | $ | 1.06 |

Additionally, the Consolidated Statement of Cash Flows has been revised to reflect the correction for the nine months ended September 30, 2019 as follows:

|  | For the Nine Months Ended September 30, (Amounts in Thousands) |
|  | 2019 |
|  | As |  |  |  |  |  |  |  |  |
|  | Previously |  |  |  |  |  |  | As |
|  | Reported |  |  | Revision |  |  | Revised |
Net income |  | $ | 15,247 |  |  | $ | (747 | ) |  | $ | 14,500 |
Deferred income taxes |  |  | 372 |  |  |  | (267 | ) |  |  | 105 |
Accounts receivable |  |  | (22,291 | ) |  |  | 2,334 |  |  |  | (19,957 | )
Accrued expenses and other long-term liabilities |  |  | (2,084 | ) |  |  | (1,320 | ) |  |  | (3,404 | )
Net cash provided by operating activities |  | $ | 8,084 |  |  | $ | — |  |  | $ | 8,084 |

4. Leases

We have historically entered into operating leases for local branches, our corporate headquarters and certain equipment. The Company’s current leases have expiration dates through 2031. Certain of our arrangements have free rent periods and/or escalating rent payment provisions. We recognize rent expense on a straight-line basis over the lease term. Certain of the Company’s leases include termination options and renewal options for periods ranging from one to five years. Because we are not reasonably certain to exercise these renewal options, the options generally are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments.

When available, we use the rate implicit in the lease to discount lease payments to present value; however, most of our leases do not provide a readily determinable implicit rate. Therefore, we must estimate our incremental borrowing rate to discount the lease payments based on information available at lease commencement.

Amounts reported in the Company’s Unaudited Condensed Consolidated Balance Sheets as of September 30, 2020 and Audited Consolidated Balance Sheets as of December 31, 2019 for our operating leases were as follows:

|  | September 30, 2020 |  |  | December 31, 2019 |
|  | (Amounts in Thousands) |
Operating lease assets, net |  | $ | 35,842 |  |  | $ | 21,111 |
Short-term operating lease liabilities (in accrued expenses) |  |  | 8,057 |  |  |  | 7,234 |
Long-term operating lease liabilities |  |  | 33,977 |  |  |  | 14,301 |
Total operating lease liabilities |  | $ | 42,034 |  |  | $ | 21,535 |

10

Table of Contents

The Company signed an eleven-year lease agreement to expand its Frisco corporate headquarters from 31,000 square feet to approximately 75,000 square feet which resulted in an increase in the operating lease asset, net, and operating lease liability by approximately $17.3 million and $22.2 million, respectively, during the three and nine months ended September 30, 2020.

Lease Costs

Components of lease cost were reported in general and administrative expenses in the Company’s Unaudited Condensed Consolidated Statements of Income as follows:

|  | For the Three Months Ended September 30, (Amounts in Thousands) |  |  | For the Nine Months Ended September 30, (Amounts in Thousands) |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Operating lease costs |  | $ | 2,285 |  |  | $ | 1,897 |  |  | $ | 6,524 |  |  | $ | 5,101 |
Short-term lease costs |  |  | 147 |  |  |  | 222 |  |  |  | 575 |  |  |  | 382 |
Total lease cost |  | $ | 2,432 |  |  | $ | 2,119 |  |  | $ | 7,099 |  |  | $ | 5,483 |

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates were as follows:

|  | September 30, 2020 |  |  | December 31, 2019 |
Operating leases: |  |  |  |  |  |  |  |
Weighted average remaining lease term |  |  | 7.24 |  |  |  | 3.42 |
Weighted average discount rate |  |  | 4.33 | % |  |  | 5.14 | %

Maturity of Lease Liabilities

A summary of our remaining operating lease payments as of September 30, 2020 were as follows:

|  | Operating Leases |
|  | (Amounts in Thousands) |
Due in the 12-month period ended September 30, |  |  |  |
2021 |  | $ | 9,176 |
2022 |  |  | 8,704 |
2023 |  |  | 6,366 |
2024 |  |  | 4,704 |
2025 |  |  | 3,549 |
Thereafter |  |  | 16,783 |
Total future minimum rental commitments |  |  | 49,282 |
Less: Imputed interest |  |  | (7,248 | )
Total lease liabilities |  | $ | 42,034 |

Supplemental cash flows information

|  | For the Nine Months Ended September 30, (Amounts in Thousands) |
|  | 2020 |  |  | 2019 |
Supplemental Cash Flows Information |  |  |  |  |  |  |  |
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |  |  |
Operating cash flows from operating leases |  | $ | 6,472 |  |  | $ | 5,393 |
Right-of-use assets, net obtained in exchange for lease obligations: |  |  |  |  |  |  |  |
Operating leases |  |  | 21,399 |  |  |  | 5,536 |

5. Acquisitions

The Company’s acquisitions have been accounted for in accordance with ASC Topic 805, Business Combinations, and the resulting goodwill and other intangible assets were accounted for under ASC Topic 350, Goodwill and Other Intangible Assets. Under business combination accounting, the assets and liabilities are generally recognized at their fair values and the difference between the consideration transferred, excluding transaction costs, and the fair values of the assets and liabilities is recognized as goodwill. The results of each business acquisition are included on the Unaudited Condensed Consolidated Statements of Income from the date of the acquisition.

11

Table of Contents

Management’s assessment of qualitative factors affecting goodwill for each acquisition includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations and the payor profile in the markets.

A Plus Health Care

On July 1, 2020, we completed the acquisition of A Plus Health Care, Inc. (“A Plus”). The purchase price was approximately $12.2 million plus the amount of excess cash held by A Plus at closing (approximately $2.8 million). The purchase of A Plus was funded with the Company’s available cash. With the purchase of A Plus, the Company expanded its personal care services in the state of Montana. The related acquisition costs were $0.3 million for the three and nine months ended September 30, 2020. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities are as follows:

|  | Total (Amounts in Thousands) |
Goodwill |  | $ | 11,252 |
Identifiable intangible assets |  |  | 1,523 |
Cash |  |  | 2,819 |
Accounts receivable |  |  | 1,075 |
Operating lease assets, net |  |  | 180 |
Other assets |  |  | 23 |
Accounts payable |  |  | (18 | )
Accrued expenses |  |  | (202 | )
Accrued payroll |  |  | (303 | )
Current portion of long-term debt |  |  | (577 | )
Long-term debt |  |  | (1,145 | )
Long-term operating lease liabilities |  |  | (100 | )
Total purchase price |  | $ | 14,527 |

Identifiable intangible assets acquired included $1.4 million in trade names with an estimated useful life of fifteen years. The preliminary estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist, using Level 3 inputs as defined under ASC Topic 820. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The A Plus acquisition accounted for $2.6 million of net service revenues and $0.5 million of operating income for the three and nine months ended September 30, 2020, respectively.

Hospice Partners

On October 1, 2019, the Company completed the acquisition of the assets of Hospice Partners of America, LLC (“Hospice Partners”). The purchase price was approximately $135.6 million. The purchase of Hospice Partners was funded through a portion of the net proceeds of our public offering of an aggregate 2,300,000 shares of common stock, par value $0.001 per share, including 300,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares at a public offering price of $79.50 per share, which the Company completed on September 9, 2019 (the “Public Offering”). With the purchase of Hospice Partners, we expanded our hospice operations through 21 locations in Idaho, Kansas, Missouri, Oregon, Texas and Virginia. The related integration costs were $1.5 million for the nine months ended September 30, 2020. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

12

Table of Contents

Based upon management’s final valuations, the fair values of the assets and liabilities are as follows:

|  | Total (Amounts in Thousands) |
Goodwill |  | $ | 111,674 |
Identifiable intangible assets |  |  | 18,090 |
Cash |  |  | 5,489 |
Property and equipment |  |  | 164 |
Accounts receivable |  |  | 6,411 |
Operating lease assets, net |  |  | 2,425 |
Other assets |  |  | 702 |
Accounts payable |  |  | (1,737 | )
Accrued expenses |  |  | (3,503 | )
Accrued payroll |  |  | (1,110 | )
Deferred tax liability |  |  | (1,422 | )
Long-term operating lease liabilities |  |  | (1,615 | )
Total purchase price |  | $ | 135,568 |

Identifiable intangible assets acquired consist of $9.5 million in trade names with estimated useful lives of fifteen years, $2.5 million in non-competition agreements with estimated useful lives of three to five years and $6.1 million of indefinite lived state licenses. The estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist, using Level 3 inputs as defined under ASC Topic 820. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Hospice Partners acquisition accounted for $13.0 million and $40.3 million of net service revenues and $3.5 million and $9.5 million of operating income for the three and nine months ended September 30, 2020, respectively.

Alliance Home Health Care

On August 1, 2019, the Company completed the acquisition of all of the assets of Alliance Home Health Care (“Alliance”). The purchase price was approximately $23.5 million. The purchase of Alliance was funded through the Company’s revolving credit facility and available cash. With the purchase of Alliance, the Company expanded its personal care, home health and hospice operations in the state of New Mexico. The related acquisition costs were $0.3 million for the three and nine months ended September 30, 2019. The related integration costs were $0.2 million for the nine months ended September 30, 2020. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Based upon management’s final valuations, the fair values of the assets and liabilities are as follows:

|  | Total (Amounts in Thousands) |
Goodwill |  | $ | 17,062 |
Identifiable intangible assets |  |  | 5,422 |
Cash |  |  | 177 |
Accounts receivable |  |  | 1,754 |
Accounts payable |  |  | (316 | )
Other liabilities |  |  | (641 | )
Total purchase price |  | $ | 23,458 |

Identifiable intangible assets acquired consist of $1.1 million in state licenses, subject to amortization, with an estimated useful life of ten years and $4.3 million of indefinite lived state licenses. The estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist, using Level 3 inputs as defined under ASC Topic 820. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Alliance acquisition accounted for $3.3 million and $3.4 million of net service revenues for the three months ended September 30, 2020 and 2019, respectively, and $12.0 million and $3.4 million for the nine months ended September 30, 2020 and 2019, respectively. Operating income accounted for $0.7 million and $0.8 million for the three months ended September 30, 2020 and 2019, respectively, and $2.7 million and $0.8 million for the nine months ended September 30, 2020 and 2019, respectively.

13

Table of Contents

VIP Health Care Services

On June 1, 2019, the Company completed the acquisition of all of the assets of VIP Health Care Services (“VIP”). The purchase price was approximately $29.9 million. The purchase of VIP was funded through a combination of the Company’s delayed draw term loan portion of its credit facility and available cash. With the purchase of VIP, the Company expanded its personal care operations in the state of New York and into the New York City metropolitan area. The related acquisition costs were $0.3 million for the nine months ended September 30, 2019. The related integration costs were $0.2 million for the nine months ended September 30, 2020, and $0.2 million and $0.3 million for the three and nine months ended September 30, 2019, respectively. These costs were included in general and administrative expenses on the Unaudited Condensed Consolidated Statements of Income and were expensed as incurred.

Based upon management’s valuations, the fair values of the assets and liabilities are as follows:

|  | Total (Amounts in Thousands) |
Goodwill |  | $ | 11,936 |
Identifiable intangible assets |  |  | 15,370 |
Cash |  |  | 130 |
Accounts receivable |  |  | 4,730 |
Operating lease assets, net |  |  | 2,278 |
Other assets |  |  | 30 |
Property and equipment |  |  | 27 |
Accounts payable |  |  | (540 | )
Accrued expenses |  |  | (770 | )
Accrued payroll |  |  | (1,742 | )
Long-term operating lease liabilities |  |  | (1,531 | )
Total purchase price |  | $ | 29,918 |

Identifiable intangible assets acquired consist of $10.7 million in state licenses, subject to amortization, and $4.7 million in customer relationships, with estimated useful lives of six and eight years, respectively. The estimated fair value of identifiable intangible assets was determined with the assistance of a valuation specialist, using Level 3 inputs as defined under ASC Topic 820. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The VIP acquisition accounted for $9.7 million and $13.2 million of net service revenues for the three months ended September 30, 2020 and 2019, respectively, and $30.5 million and $17.6 million for the nine months ended September 30, 2020 and 2019, respectively, and $0.4 million of operating loss for each of the three months ended September 30, 2020 and 2019, and $1.1 million and $0.1 million of operating loss for the nine months ended September 30, 2020 and 2019, respectively.

The following table contains unaudited pro forma condensed consolidated income statement information of the Company for the three and nine months ended September 30, 2020 and 2019 as if each of the acquisitions of Hospice Partners, Alliance, VIP and A Plus closed on January 1, 2019.

|  | For the Three Months Ended September 30, (Amounts in Thousands) |  |  | For the Nine Months Ended September 30, (Amounts in Thousands) |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
Net service revenues |  | $ | 193,987 |  |  | $ | 187,846 |  |  | $ | 573,917 |  |  | $ | 541,646 |
Operating income from continuing operations |  |  | 12,269 |  |  |  | 9,291 |  |  |  | 32,136 |  |  |  | 26,328 |
Net income from continuing operations |  |  | 9,458 |  |  |  | 6,922 |  |  |  | 25,663 |  |  |  | 20,518 |
Net income per common share from continuing operations |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic income per share |  | $ | 0.61 |  |  | $ | 0.50 |  |  | $ | 1.65 |  |  | $ | 1.55 |

The pro forma disclosures in the table above include adjustments for amortization of intangible assets, tax expense and acquisition costs to reflect results that are more representative of the combined results of the transactions as if Hospice Partners, Alliance, VIP and A Plus had been acquired effective January 1, 2019. This pro forma information is presented for illustrative purposes only and may not be indicative of the results of operations that would have actually occurred. In addition, future results may vary significantly from the results reflected in the pro forma information. The unaudited pro forma financial information does not reflect the impact of future events that may occur after the acquisition, such as anticipated cost savings from operating synergies.

14

Table of Contents

6. Goodwill and Intangible Assets

A summary of the goodwill activity for the nine months ended September 30, 2020 is provided below:

|  | Goodwill |
|  | Personal Care |  |  | Hospice |  |  | Home Health |  |  | Total |
|  | (Amounts in Thousands) |
Goodwill as of December 31, 2019 |  | $ | 126,577 |  |  | $ | 146,983 |  |  | $ | 1,808 |  |  | $ | 275,368 |
Additions for acquisition |  |  | 11,252 |  |  |  | — |  |  |  | — |  |  |  | 11,252 |
Divestiture |  |  | — |  |  |  | (1,167 | ) |  |  | — |  |  |  | (1,167 | )
Adjustments to previously recorded goodwill |  |  | 1,438 |  |  |  | (322 | ) |  |  | (17 | ) |  |  | 1,099 |
Goodwill as of September 30, 2020 |  | $ | 139,267 |  |  | $ | 145,494 |  |  | $ | 1,791 |  |  | $ | 286,552 |

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names, trademarks and non-competition agreements. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from three to twenty-five years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from five to ten years. Goodwill and certain state licenses are not amortized pursuant to ASC Topic 350.

The Company recognized goodwill in the personal care segment of $11.3 million related to the acquisition of A Plus during the nine months ended September 30, 2020. For the three and nine months ended September 30, 2020, adjustments to previously recorded goodwill are primarily adjustments to accounts receivable based on the final valuations for the acquisitions of Hospice Partners, Alliance and VIP. During the nine months ended September 30, 2020, the Company divested certain branches and their related net assets including $1.2 million of related goodwill. The Company recognized $0.3 million loss on the disposition, reflected as a reduction in general and administrative expense for the nine months ended September 30, 2020.

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following as of September 30, 2020:

|  | Customer and referral relationships |  |  | Trade names and trademarks |  |  | Non- competition agreements |  |  | State Licenses |  |  | Total |
|  | (Amounts in Thousands) |
Intangible assets with indefinite lives |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 13,296 |  |  |  | 13,296 |
Intangible assets subject to amortization: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Gross carrying amount |  |  | 48,028 |  |  |  | 31,946 |  |  |  | 4,655 |  |  |  | 12,164 |  |  |  | 96,793 |
Accumulated amortization |  |  | (37,263 | ) |  |  | (14,671 | ) |  |  | (2,716 | ) |  |  | (2,566 | ) |  |  | (57,216 | )
Intangible assets subject to amortization, net |  |  | 10,765 |  |  |  | 17,275 |  |  |  | 1,939 |  |  |  | 9,598 |  |  |  | 39,577 |
Total intangible assets at September 30, 2020 |  | $ | 10,765 |  |  | $ | 17,275 |  |  | $ | 1,939 |  |  | $ | 22,894 |  |  | $ | 52,873 |

During the nine months ended September 30, 2020, the Company acquired a trade name of $1.4 million related to the acquisition of A Plus. Amortization expense related to identifiable intangible assets amounted to $1.7 million and $5.3 million for the three and nine months ended September 30, 2020, respectively, and $1.8 million and $4.4 million for the three and nine months ended September 30, 2019, respectively. The weighted average remaining lives of identifiable intangible assets as of September 30, 2020 is 8.7 years.

7. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consisted of the following:

|  | September 30, 2020 |  |  | December 31, 2019 |
|  | (Amounts in Thousands) |
Income tax receivable |  | $ | 2,533 |  |  | $ | — |
Workers’ compensation insurance receivable |  |  | 2,186 |  |  |  | 1,989 |
Prepaid workers' compensation and liability insurance |  |  | 1,792 |  |  |  | 2,040 |
Health insurance receivable |  |  | 426 |  |  |  | 1,567 |
Other |  |  | 3,489 |  |  |  | 2,397 |
Total prepaid expenses and other current assets |  | $ | 10,426 |  |  | $ | 7,993 |

15

Table of Contents

Accrued expenses consisted of the following:

|  | September 30, 2020 |  |  | December 31, 2019 |
|  | (Amounts in Thousands) |
Accrued payroll taxes (1) |  | $ | 8,448 |  |  | $ | 1,843 |
Current portion of operating lease liabilities |  |  | 8,057 |  |  |  | 7,234 |
Accrued health insurance |  |  | 4,413 |  |  |  | 4,140 |
Accrued professional fees |  |  | 3,135 |  |  |  | 2,517 |
Other |  |  | 9,342 |  |  |  | 6,695 |
Total accrued expenses |  | $ | 33,395 |  |  | $ | 22,429 |

(1) | The Company deferred $7.1 million of payroll taxes in connection to a provision included in the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), see Note 10 to the Notes to Consolidated Financial Statements for additional information.

8. Long-Term Debt

Long-term debt consisted of the following:

|  | September 30, 2020 |  |  | December 31, 2019 |
|  | (Amounts in Thousands) |
Revolving loan under the credit facility |  | $ | 43,458 |  |  | $ | 43,458 |
Term loan under the credit facility |  |  | 18,375 |  |  |  | 18,865 |
Other debt |  |  | 1,722 |  |  |  | — |
Financing leases |  |  | — |  |  |  | 21 |
Less unamortized issuance costs |  |  | (1,899 | ) |  |  | (2,452 | )
Total |  | $ | 61,656 |  |  | $ | 59,892 |
Less current maturities |  |  | (2,095 | ) |  |  | (728 | )
Long-term debt |  | $ | 59,561 |  |  | $ | 59,164 |

Amended and Restated Senior Secured Credit Facility

On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, dated as of October 31, 2018, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders (as amended by the Amendment (as hereinafter defined), the “Credit Agreement”), which amended and restated the Company’s existing credit agreement. This credit facility totaled $269.6 million, inclusive of a $250.0 million revolving loan and a $19.6 million delayed draw term loan, and is evidenced by the Credit Agreement. This credit facility amended and restated the Company’s existing senior secured credit facility totaling $250.0 million. As used throughout this Quarterly Report on Form 10-Q, “credit facility” shall mean the credit facility evidenced by the Credit Agreement. The maturity of this credit facility is May 8, 2023. Interest on the Company’s credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50% and (c) the sum of the adjusted LIBOR that would be applicable to a loan with an interest period of one month advanced on the applicable day (not to be less than 0.00%) plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the offered rate per annum for similar dollar deposits for the applicable interest period that appears on Reuters Screen LIBOR01 Page (not to be less than zero). Swing loans may not be LIBOR loans. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters. In connection with this amended and restated credit facility, the Company incurred approximately $0.9 million of debt issuance costs.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this amended and restated credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions and dispositions of assets.

On September 12, 2019, the Company entered into a First Amendment (the “Amendment”) to its Credit Agreement. The Amendment increased the Company’s credit facility by $50.0 million in incremental revolving loans, for an aggregate $300.0 million in revolving loans. The Amendment provides that future incremental loans may be for term loans or an increase to the revolving loan commitments. The Amendment further provides that the proceeds of the incremental revolving loan commitments may be used for, among other things, general corporate purposes. In connection with the modification of this Amendment, the Company incurred approximately $0.4 million of debt issuance costs.

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the amended and restated credit facility.

16

Table of Contents

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement), a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum permitted amount of capital expenditures, as well as restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $7.5 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement thresholds), restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business. As of September 30, 2020, the Company was in compliance with all financial covenants under the Credit Agreement.

During the nine months ended September 30, 2020, the Company had no draws under its credit facility.

As of September 30, 2020, the Company had a total of $43.4 million of revolving loans, with an interest rate of 1.89% and $18.4 million of term loans, with an interest rate of 1.89%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $9.3 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $219.0 million available for borrowing under its credit facility.

As of December 31, 2019, the Company had a total of $43.4 million of revolving loans, with an interest rate of 3.44%, and $18.9 million of term loans, with an interest rate of 3.45%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $10.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $191.4 million available for borrowing under its credit facility.

9. Income Taxes

The effective income tax rates are 23.6% and 24.4% for the three months ended September 30, 2020 and 2019, respectively. For the three months ended September 30, 2020 and 2019, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes and non-deductible compensation, partially offset by an excess tax benefit and the use of federal employment tax credits.

The effective income tax rates are 20.5% and 21.3% for the nine months ended September 30, 2020 and 2019, respectively. For the nine months ended September 30, 2020 and 2019, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of an excess tax benefit and the use of federal employment tax credits partially offset by state taxes and non-deductible compensation. The excess tax benefit is a discrete item, related to the vesting of equity shares, which requires the Company to recognize the benefit fully in the period. An excess tax benefit results if the Company’s income tax deduction exceeds the cumulative costs of the award recognized on the Unaudited Condensed Consolidated Statements of Income.

10. Commitments and Contingencies

Legal Proceedings

From time to time, we are subject to legal and/or administrative proceedings incidental to our business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on the Company’s Unaudited Condensed Consolidated Balance Sheets and Unaudited Condensed Consolidated Statements of Income.

Government Actions to Mitigate COVID-19’s Impact

On January 31, 2020, the Secretary of the U.S. Department of Health and Human Services (“HHS”) declared a national public health emergency due to a novel coronavirus. In March 2020, the World Health Organization declared the outbreak of COVID-19, a disease caused by this novel coronavirus, a pandemic. This disease has spread throughout the United States and other parts of the world, and COVID-19 cases have recently been increasing in the United States and Europe. It is impossible to predict the effect and ultimate impact of the COVID-19 pandemic as the situation continues to rapidly evolve.

17

Table of Contents

In recognition of the significant threat to the liquidity of financial markets posed by the COVID-19 pandemic, the Federal Reserve and Congress have taken dramatic actions to provide liquidity to businesses and the banking system in the United States. For example, on March 27, 2020, the President signed into law the CARES Act, a sweeping stimulus bill intended to bolster the U.S. economy. On April 24, 2020, the Paycheck Protection Program and Health Care Enhancement Act (“PPPHCE Act”) was enacted, an expansion of the CARES Act. Together, the CARES Act and the PPPHCE Act authorize $175 billion in funding to be distributed to health care providers through the Relief Fund. This funding is intended to support healthcare providers by reimbursing them for healthcare-related expenses or lost revenues attributable to COVID-19. In addition to relief funding, the CARES Act includes temporary changes to Medicare and Medicaid payment rules and relief from certain accounting provisions.

In April 2020, the Company received grants in an aggregate principal amount of $6.9 million, for which it did not apply, from the Relief Fund as part of the automatic general distributions by HHS. The Company returned these funds in June 2020. The CARES Act includes provisions relating to refundable payroll tax credits, deferral of the employer portion of certain payroll taxes, net operating loss carrybacks, and other areas. The payroll tax deferral requires that the deferred payroll taxes be paid over two years, with half of the amount required to be paid by December 31, 2021 and the other half by December 31, 2022. The Company elected to defer payroll taxes during the quarter ended June 30, 2020 and ceased the deferral election effective June 30, 2020. The Company deferred $7.1 million of payroll taxes, which are included in accrued expenses in the Company’s Unaudited Condensed Consolidated Balance Sheets at September 30, 2020.

11. Segment Information

Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s chief operating decision makers, to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three distinct but related business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy.

The tables below set forth information about the Company’s reportable segments for the three and nine months ended September 30, 2020 and 2019 along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements. Segment assets are not reviewed by the Company’s chief operating decision maker function and therefore are not disclosed below.

Segment operating income consists of revenue generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

|  | For the Three Months Ended September 30, 2020 |
|  | (Amounts in Thousands) |
|  | Personal Care |  |  | Hospice |  |  | Home Health |  |  | Total |
Net service revenues |  | $ | 165,916 |  |  | $ | 23,986 |  |  | $ | 4,085 |  |  | $ | 193,987 |
Cost of services revenues |  |  | 124,493 |  |  |  | 10,508 |  |  |  | 2,685 |  |  |  | 137,686 |
Gross profit |  |  | 41,423 |  |  |  | 13,478 |  |  |  | 1,400 |  |  |  | 56,301 |
General and administrative expenses |  |  | 14,837 |  |  |  | 5,904 |  |  |  | 925 |  |  |  | 21,666 |
Segment operating income |  | $ | 26,586 |  |  | $ | 7,574 |  |  | $ | 475 |  |  | $ | 34,635 |

|  | For the Three Months Ended September 30, 2019 |
|  | (Amounts in Thousands) |
|  | Personal Care |  |  | Hospice |  |  | Home Health |  |  | Total |
Net service revenues |  | $ | 153,753 |  |  | $ | 10,874 |  |  | $ | 4,366 |  |  | $ | 168,993 |
Cost of services revenues |  |  | 115,504 |  |  |  | 5,495 |  |  |  | 2,818 |  |  |  | 123,817 |
Gross profit |  |  | 38,249 |  |  |  | 5,379 |  |  |  | 1,548 |  |  |  | 45,176 |
General and administrative expenses |  |  | 14,737 |  |  |  | 1,824 |  |  |  | 844 |  |  |  | 17,405 |
Segment operating income |  | $ | 23,512 |  |  | $ | 3,555 |  |  | $ | 704 |  |  | $ | 27,771 |

18

Table of Contents

|  | For the Three Months Ended September 30, |
|  | 2020 |  |  | 2019 |
|  | (Amounts in Thousands) |
Segment reconciliation: |  |  |  |  |  |  |  |
Total segment operating income |  | $ | 34,635 |  |  | $ | 27,771 |
Items not allocated at segment level: |  |  |  |  |  |  |  |
Other general and administrative expenses |  |  | 19,067 |  |  |  | 17,680 |
Depreciation and amortization |  |  | 3,045 |  |  |  | 2,756 |
Interest income |  |  | (87 | ) |  |  | (786 | )
Interest expense |  |  | 680 |  |  |  | 866 |
Income before income taxes |  | $ | 11,930 |  |  | $ | 7,255 |

|  | For the Nine Months Ended September 30, 2020 |
|  | (Amounts in Thousands) |
|  | Personal Care |  |  | Hospice |  |  | Home Health |  |  | Total |
Net service revenues |  | $ | 482,849 |  |  | $ | 73,723 |  |  | $ | 12,207 |  |  | $ | 568,779 |
Cost of services revenues |  |  | 359,344 |  |  |  | 33,749 |  |  |  | 8,553 |  |  |  | 401,646 |
Gross profit |  |  | 123,505 |  |  |  | 39,974 |  |  |  | 3,654 |  |  |  | 167,133 |
General and administrative expenses |  |  | 45,042 |  |  |  | 18,658 |  |  |  | 2,831 |  |  |  | 66,531 |
Segment operating income |  | $ | 78,463 |  |  | $ | 21,316 |  |  | $ | 823 |  |  | $ | 100,602 |

|  | For the Nine Months Ended September 30, 2019 |
|  | (Amounts in Thousands) |
|  | Personal Care |  |  | Hospice |  |  | Home Health |  |  | Total |
Net service revenues |  | $ | 419,124 |  |  | $ | 27,228 |  |  | $ | 10,063 |  |  | $ | 456,415 |
Cost of services revenues |  |  | 314,329 |  |  |  | 13,587 |  |  |  | 6,803 |  |  |  | 334,719 |
Gross profit |  |  | 104,795 |  |  |  | 13,641 |  |  |  | 3,260 |  |  |  | 121,696 |
General and administrative expenses |  |  | 40,053 |  |  |  | 4,962 |  |  |  | 2,187 |  |  |  | 47,202 |
Segment operating income |  | $ | 64,742 |  |  | $ | 8,679 |  |  | $ | 1,073 |  |  | $ | 74,494 |

|  | For the Nine Months Ended September 30, |
|  | 2020 |  |  | 2019 |
|  | (Amounts in Thousands) |
Segment reconciliation: |  |  |  |  |  |  |  |
Total segment operating income |  | $ | 100,602 |  |  | $ | 74,494 |
Items not allocated at segment level: |  |  |  |  |  |  |  |
Other general and administrative expenses |  |  | 58,939 |  |  |  | 46,907 |
Depreciation and amortization |  |  | 8,872 |  |  |  | 7,365 |
Interest income |  |  | (576 | ) |  |  | (1,096 | )
Interest expense |  |  | 2,309 |  |  |  | 2,164 |
Income before income taxes |  | $ | 31,058 |  |  | $ | 19,154 |

19

Table of Contents

12. Significant Payors

For the three and nine months ended September 30, 2020 and 2019, the Company’s revenue by payor type was as follows:

|  | Personal Care |  |
|  | For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30, |  |
|  | 2020 |  |  |  | 2019 |  |  |  | 2020 |  |  |  | 2019 |  |
|  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |
State, local and other governmental programs |  | $ | 85,344 |  |  |  | 51.5 |  | % |  | $ | 75,176 |  |  |  | 48.9 |  | % |  | $ | 242,751 |  |  |  | 50.3 |  | % |  | $ | 221,450 |  |  |  | 52.8 |  | %
Managed care organizations |  |  | 71,700 |  |  |  | 43.2 |  |  |  |  | 68,438 |  |  |  | 44.5 |  |  |  |  | 213,087 |  |  |  | 44.1 |  |  |  |  | 170,004 |  |  |  | 40.6 |  |
Private pay |  |  | 5,193 |  |  |  | 3.1 |  |  |  |  | 5,720 |  |  |  | 3.7 |  |  |  |  | 15,449 |  |  |  | 3.2 |  |  |  |  | 15,912 |  |  |  | 3.8 |  |
Commercial insurance |  |  | 2,498 |  |  |  | 1.5 |  |  |  |  | 2,683 |  |  |  | 1.8 |  |  |  |  | 7,468 |  |  |  | 1.5 |  |  |  |  | 6,569 |  |  |  | 1.6 |  |
Other |  |  | 1,181 |  |  |  | 0.7 |  |  |  |  | 1,736 |  |  |  | 1.1 |  |  |  |  | 4,094 |  |  |  | 0.9 |  |  |  |  | 5,189 |  |  |  | 1.2 |  | %
Total personal care segment net service revenues |  | $ | 165,916 |  |  |  | 100.0 |  | % |  | $ | 153,753 |  |  |  | 100.0 |  | % |  | $ | 482,849 |  |  |  | 100.0 |  | % |  | $ | 419,124 |  |  |  | 100.0 |  |

|  | Hospice
|  | For the Three Months Ended September 30, |  |  | For the Nine Months Ended September 30,
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |  |
|  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |
Medicare |  | $ | 22,404 |  |  |  | 93.4 |  | % | $ | 10,045 |  |  |  | 92.4 |  | % | $ | 68,372 |  |  |  | 92.8 |  | % | $ | 25,243 |  |  |  | 92.7 |  | %
Managed care organizations |  |  | 1,130 |  |  |  | 4.7 |  |  |  | 584 |  |  |  | 5.4 |  |  |  | 3,710 |  |  |  | 5.0 |  |  |  | 1,419 |  |  |  | 5.2 |  |
Other |  |  | 452 |  |  |  | 1.9 |  |  |  | 245 |  |  |  | 2.2 |  |  |  | 1,641 |  |  |  | 2.2 |  |  |  | 566 |  |  |  | 2.1 |  |
Total hospice segment net service revenues |  | $ | 23,986 |  |  |  | 100.0 |  | % | $ | 10,874 |  |  |  | 100.0 |  | % | $ | 73,723 |  |  |  | 100.0 |  | % | $ | 27,228 |  |  |  | 100.0 |  | %

|  | Home Health
|  | For the Three Months Ended September 30, |  |  | For the Nine Months Ended September 30,
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |  |
|  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |
Medicare |  | $ | 3,188 |  |  |  | 78.0 |  | % | $ | 3,338 |  |  |  | 76.5 |  | % | $ | 9,667 |  |  |  | 79.2 |  | % | $ | 7,948 |  |  |  | 79.0 |  | %
Managed care organizations |  |  | 829 |  |  |  | 20.3 |  |  |  | 959 |  |  |  | 22.0 |  |  |  | 2,325 |  |  |  | 19.0 |  |  |  | 1,872 |  |  |  | 18.6 |  |
Other |  |  | 68 |  |  |  | 1.7 |  |  |  | 69 |  |  |  | 1.5 |  |  |  | 215 |  |  |  | 1.8 |  |  |  | 243 |  |  |  | 2.4 |  |
Total home health segment net service revenues |  | $ | 4,085 |  |  |  | 100.0 |  | % | $ | 4,366 |  |  |  | 100.0 |  | % | $ | 12,207 |  |  |  | 100.0 |  | % | $ | 10,063 |  |  |  | 100.0 |  | %

The Company derives a significant amount of its revenue from its operations in Illinois, New York and New Mexico. The percentages of segment revenue for each of these significant states for the three and nine months ended September 30, 2020 and 2019 were as follows:

|  | Personal Care |  |
|  | For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30, |  |
|  | 2020 |  |  |  | 2019 |  |  |  | 2020 |  |  |  | 2019 |  |
|  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |
Illinois |  | $ | 74,448 |  |  |  | 44.9 |  | % |  | $ | 61,633 |  |  |  | 40.1 |  | % |  | $ | 215,047 |  |  |  | 44.6 |  | % |  | $ | 178,449 |  |  |  | 42.5 |  | %
New York |  |  | 28,381 |  |  |  | 17.1 |  |  |  |  | 34,730 |  |  |  | 22.6 |  |  |  |  | 87,463 |  |  |  | 18.1 |  |  |  |  | 75,330 |  |  |  | 18.0 |  |
New Mexico |  |  | 21,878 |  |  |  | 13.2 |  |  |  |  | 19,559 |  |  |  | 12.7 |  |  |  |  | 64,402 |  |  |  | 13.3 |  |  |  |  | 54,701 |  |  |  | 13.1 |  |
All other states |  |  | 41,209 |  |  |  | 24.8 |  |  |  |  | 37,831 |  |  |  | 24.6 |  |  |  |  | 115,937 |  |  |  | 24.0 |  |  |  |  | 110,644 |  |  |  | 26.4 |  |
Total personal care segment net service revenues |  | $ | 165,916 |  |  |  | 100.0 |  | % |  | $ | 153,753 |  |  |  | 100.0 |  | % |  | $ | 482,849 |  |  |  | 100.0 |  | % |  | $ | 419,124 |  |  |  | 100.0 |  | %

20

Table of Contents

|  | Hospice |  |
|  | For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30, |  |
|  | 2020 |  |  |  | 2019 |  |  |  | 2020 |  |  |  | 2019 |  |
|  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |
New Mexico |  | $ | 10,979 |  |  |  | 45.8 |  | % |  | $ | 10,874 |  |  |  | 100.0 |  | % |  | $ | 33,431 |  |  |  | 45.3 |  | % |  | $ | 27,228 |  |  |  | 100.0 |  | %
All other states |  |  | 13,007 |  |  |  | 54.2 |  |  |  |  | — |  |  |  | — |  |  |  |  | 40,292 |  |  |  | 54.7 |  |  |  |  | — |  |  |  | — |  |
Total hospice segment net service revenues |  | $ | 23,986 |  |  |  | 100.0 |  | % |  | $ | 10,874 |  |  |  | 100.0 |  | % |  | $ | 73,723 |  |  |  | 100.0 |  | % |  | $ | 27,228 |  |  |  | 100.0 |  | %

|  | Home Health |  |
|  | For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30, |  |
|  | 2020 |  |  |  | 2019 |  |  |  | 2020 |  |  |  | 2019 |  |
|  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |
New Mexico |  | $ | 4,085 |  |  |  | 100.0 |  | % |  | $ | 4,366 |  |  |  | 100.0 |  | % |  | $ | 12,207 |  |  |  | 100.0 |  | % |  | $ | 10,063 |  |  |  | 100.0 |  | %
Total home health segment net service revenues |  | $ | 4,085 |  |  |  | 100.0 |  | % |  | $ | 4,366 |  |  |  | 100.0 |  | % |  | $ | 12,207 |  |  |  | 100.0 |  | % |  | $ | 10,063 |  |  |  | 100.0 |  | %

A substantial portion of the Company’s revenue and accounts receivable are derived from services performed for federal, state and local governmental agencies. We derive a significant amount of our net service revenues in Illinois, which represented 38.5%, and 36.4% of our net service revenues for the three months ended September 30, 2020, and 2019, respectively and accounted for 37.8% and 39.1% of our net service revenues for the nine months ended September 30, 2020 and 2019, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 22.9% and 22.1% of the Company’s net service revenues for the three months ended September 30, 2020 and 2019, respectively, and accounted for 23.1% and 26.0% of the Company’s net service revenues for the nine months ended September 30, 2020 and 2019, respectively.

The related receivables due from the Illinois Department on Aging represented 18.5% and 25.1% of the Company’s net accounts receivable at September 30, 2020 and December 31, 2019, respectively.

13. Subsequent Events

On November 1, 2020, we completed the acquisition of County Homemakers Incorporated (“County Homemakers”) for approximately $14.6 million, with funding provided by cash on hand. With the purchase of County Homemakers, we expanded our personal care services in the state of Pennsylvania. The Company is currently assessing the fair value of identifiable net assets acquired.

21

Table of Contents

ITEM 2. | MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements about our business and operations. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words like “believes,” “belief,” “expects,” “plans,” “anticipates,” “intends,” “projects,” “estimates,” “may,” “might,” “would,” “should” and similar expressions are intended to be forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements are based on the beliefs and assumptions of our management based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other important factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, the anticipated impact to our business operations with respect to developments related to the COVID-19 pandemic, including, without limitation, those related to the length and severity of the pandemic, as well as the timing and availability of effective medical treatments and vaccines; the pandemic’s impact on our business operations, reimbursement and our consumer population; measures we are taking to respond to the pandemic; the impact of government regulation and stimulus measures, including the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), Paycheck Protection Program and Health Care Enhancement Act (“PPPHCE Act”) and other enacted legislation; increased expenses related to personal protective equipment, labor, supply chain, or other expenditures; and workforce disruptions and supply shortages and disruptions; uncertainty regarding the implementation of the CARES Act, the PPPHCE Act, and any other future stimulus measures related to COVID-19; changes in operational and reimbursement processes and payment structures at the state or federal levels; changes in Medicaid, Medicare, other government program and managed care organizations policies and payment rates; changes in, or our failure to comply with, existing, federal and state laws or regulations, or our failure to comply with new government laws or regulations on a timely basis; competition in the healthcare industry; the geographical concentration of our operations; changes in the case mix of consumers and payment methodologies; operational changes resulting from the assumption by managed care organizations of responsibility for managing and paying for our services to consumers; the nature and success of future financial and/or delivery system reforms; changes in estimates and judgments associated with critical accounting policies; our ability to maintain or establish new referral sources; our ability to renew significant agreements or groups of agreements; our ability to attract and retain qualified personnel; federal, city and state minimum wage pressure, including any failure of Illinois or any other governmental entity to enact a minimum wage offset and/or the timing of any such enactment; changes in payments and covered services due to the overall economic conditions, including economic and business conditions resulting from the COVID-19 pandemic, and deficit spending by federal and state governments; cost containment initiatives undertaken by state and other third-party payors; our ability to access financing through the capital and credit markets; our ability to meet debt service requirements and comply with covenants in debt agreements; business disruptions due to natural disasters, acts of terrorism, pandemics, riots, civil insurrection or social unrest, looting, protests, strikes or street demonstrations; our ability to integrate and manage our information systems; our expectations regarding the size and growth of the market for our services; the acceptance of privatized social services; our expectations regarding changes in reimbursement rates; eligibility standards and limits on services imposed by state governmental agencies; the potential for litigation; discretionary determinations by government officials; our ability to successfully implement our business model to grow our business; our ability to continue identifying, pursuing, consummating and integrating acquisition opportunities and expand into new geographic markets; the impact of acquisitions and dispositions on our business, including the potential inability to realize the benefits of the acquisition of Hospice Partners; the potential impact of the discontinuation or modification of LIBOR; the effectiveness, quality and cost of our services; our ability to successfully execute our growth strategy; changes in tax rates; the impact of public health emergencies; the impact of inclement weather or natural disasters, including the COVID-19 pandemic; and various other matters, many of which are beyond our control. In addition, the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the period ended December 31, 2019, filed on August 10, 2020 may result in these differences. You should carefully review all of these factors. These forward-looking statements were based on information, plans and estimates at the date of this report, and we assume no obligation to update any forward-looking statements to reflect changes in underlying assumptions or factors, new information, future events or other changes, except as may be required by law.

Overview

The unaudited condensed consolidated financial statements for the three and nine months ended September 30, 2019 have been revised to correct prior period errors as discussed in Note 3, “Revision of Previously Issued Financial Statements” to the Notes to Consolidated Financial Statements and in Note 2, “Revision of Previously Issued Financial Statements” and Note 17, “Unaudited Summarized Quarterly Financial Information” to our consolidated financial statements included in Part II, Item 8—“Financial Statements and Supplementary Data,” of our Annual Report on Form 10-K for the period ended December 31, 2019, filed on August 10, 2020. Accordingly, this MD&A reflects the impact of those revisions.

We are a home care services provider operating in three segments: personal care, hospice, and home health. Our services are provided in-home under agreements with federal, state and local government agencies, managed care organizations, commercial insurers and private individuals. Our consumers are predominantly “dual eligible,” meaning they are eligible to receive both Medicare and Medicaid benefits. Managed care revenues accounted for 38.0% and 41.4% of our revenue during the three months ended September 30, 2020 and 2019, respectively, and 38.5% and 38.0% of our revenue during the nine months ended September 30, 2020 and 2019, respectively.

22

Table of Contents

A summary of our financial results for the three and nine months ended September 30, 2020 and 2019 is provided in the table below.

|  | For the Three Months Ended September 30, |  |  | For the Nine Months Ended September 30, |
|  | 2020 |  |  | 2019 |  |  | 2020 |  |  | 2019 |
|  | (Amounts in Thousands) |  |  | (Amounts in Thousands) |
Net service revenues - continuing operations |  | $ | 193,987 |  |  | $ | 168,993 |  |  | $ | 568,779 |  |  | $ | 456,415 |
Net income from continuing operations |  |  | 9,119 |  |  |  | 5,486 |  |  |  | 24,684 |  |  |  | 15,074 |
Net loss from discontinued operations |  |  | — |  |  |  | (574 | ) |  |  | — |  |  |  | (574 | )
Net income |  | $ | 9,119 |  |  | $ | 4,912 |  |  | $ | 24,684 |  |  | $ | 14,500 |

As of September 30, 2020, we provided our services in 24 states through 193 offices. For the nine months ended September 30, 2020 and 2019, we served approximately 59,000 and 57,000 discrete individuals, respectively. Our personal care segment also includes staffing services, with clients including assisted living facilities, nursing homes and hospice facilities.

COVID-19 Pandemic

On January 31, 2020, the HHS Secretary declared a national public health emergency due to a novel coronavirus. In March 2020, the World Health Organization declared the outbreak of COVID-19, the disease caused by this novel coronavirus, a pandemic. This disease has spread throughout the United States and other parts of the world, with a recent increase in cases in the United States and Europe. State and local governments, together with public health officials, have recommended and mandated precautions to mitigate the spread of the virus, including closures of and limitations on public facilities, parks, schools, restaurants, many businesses and other locations of public assembly. As a result, COVID-19 has significantly affected overall economic conditions in the United States. Although many of the restrictions have eased across the country, some areas are re-imposing closures and other restrictions as a result of increasing rates of COVID-19 infection. The FDA continues to facilitate the development of therapeutics to combat COVID-19 as well as provide oversight for the development of a vaccine. There are no reliable estimates of how long the pandemic will last, how many people are likely to be affected by it or the duration or types of restrictions that will be imposed or re-imposed as the situation is continuously evolving. For that reason, we are unable to predict the long-term impact of the pandemic on our business at this time.

We continue to monitor the impacts on our operations, and have taken precautions intended to minimize the risk to our employees and patients. We have created a COVID-19 Response Team that is responsible for creating and communicating policy, training and the latest COVID-19 updates to all employees. Most employees in our headquarters in Frisco, TX, and in Downers’ Grove, IL, continue to work remotely, and do not believe this arrangement has had a material impact on our ability to maintain business operations.

For the three and nine months ended September 30, 2020, COVID-19 related costs were approximately $2.5 million and $4.8 million, respectively, which were mostly offset by temporary rate increases from certain payors, in our personal care segment, of $1.8 million and $3.6 million during the three and nine months ended September 30, 2020. As of September 30, 2020, $3.0 million of payments received from payors for COVID-19 reimbursements have been recorded as deferred revenue and will be recognized as we incur related expenses on behalf of the payor. Three of our primary markets, New Mexico, New York and Illinois, have been significantly affected by the pandemic, with high numbers of cases reported. However, relevant authorities have universally designated our services as “essential services,” exempting our services and service providers from many of the restrictions described above. In addition, the impact of the restrictions on the Company’s operations for our consumer population has been minimal. For example, in our personal care services segment, we provide non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. Most of these consumers are largely confined to their homes, and a significant number of our caregivers provide services to only one consumer, often a family member. We have implemented several new procedures to further reduce the risk of COVID-19 transmission, including a new screening process for both the caregiver and the consumer and the expansion of the use of personal protective equipment from our hospice and home health segments to include our personal care segment. We are not able to reasonably predict the total amount of costs we will incur related to the COVID-19 pandemic, and such costs could be substantial. According to the Centers for Disease Control and Prevention, older adults and people with certain underlying medical conditions are at a higher risk for serious illness from COVID-19.

Prior to the widespread impacts of COVID-19, the primary limitation on our growth had been the difficulty to attract and retain sufficient caregivers in an environment of very low unemployment rates. Under the CARES Act, all states provide 13 additional weeks of federally funded Pandemic Emergency Unemployment Assistance benefits to people who exhaust their regular state benefits, followed by additional weeks of federally funded unemployment benefits in states with high unemployment (up to 13 or 20 weeks depending on state laws). With the widespread adverse impacts of the COVID-19 pandemic on the hospitality and other labor-intensive industries, we believe we will have an opportunity to increase our hiring of new caregivers. However, in the near term, the enhanced unemployment benefits offered by several states have suppressed the opportunity to tap into this new pool of potential caregivers in these states. For example in September 2020, the state of New York announced the Lost Wages Assistance (“LWA”) program, which provides an additional $300 in weekly benefits to unemployed individuals.

For the three and nine months ended September 30, 2020, the COVID-19 pandemic had limited impact on our reimbursements. Although we experienced some consumers suspending their personal care services due to health concerns, many of these consumers resumed our services within weeks. This reduction was partially offset by an increase in demand for our services by patients recovering from COVID-19 who have been released from the hospital but are still suffering lingering effects of the virus.

The economic slowdown caused by the COVID-19 pandemic pose significant risks to states’ budgets for the 2021 fiscal year, which began July 1 in most states. Depending on the severity and length of a downturn, sales tax collections and income tax withholdings could continue to be depressed in fiscal 2021 and, potentially, future fiscal years. States could face significant fiscal challenges and may have no choice but to revise

23

Table of Contents

their revenue forecasts and adjust their budge ts for fiscal 2021 and, potentially, future fiscal years, accordingly. Indeed, Illinois, New York and New Mexico, our top three markets, have revised revenue estimates down for the 2021 fiscal year. In New York, which started its fiscal year April 1, the s tate comptroller recently estimated that the state would collect at least $10 billion less than originally forecasted, the first year-to-year cut since 2011. The current New York fiscal plan authorizes the state of New York to issue up to $8 billion in sho rt-term bonds to provide funds in case of reduced revenues during the fiscal year. The state issued $1.1 billion of bonds on October 28, 2020. The New York fiscal plan also allows two state authorities to provide the state with a $3 billion line of credit in the new fiscal year. Congress could provide additional relief with additional stimulus and relief legislation, including extension of unemployment benefits and relief for states. We cannot determine the impact that COVID-19 may have on states budgets fo r 2021 or beyond, however, such impacts could have a material adverse effect on our financial condition, results of operations and cash flows.

At September 30, 2020, we had $170.3 million of cash on hand and $219.0 million of available, unused committed capacity under our credit facility. Our credit facility requires us to maintain a total net leverage ratio not exceeding 3.75:1.00. As of September 30, 2020, our total net leverage ratio was zero. Although we believe our liquidity position remains strong, we can provide no assurance that we will remain in compliance with the covenants in our Credit Agreement, and in the future, it may prove necessary to seek an amendment with the bank lending group under our credit facility. The COVID-19 pandemic has resulted in, and may continue to result in, significant disruption of financial and capital markets, and there can be no assurance that we will be able to raise additional funds on terms acceptable to us, if at all.

The impact of the COVID-19 pandemic is fluid and continues to evolve, and, therefore, we cannot currently predict with certainty the extent to which our business, results of operations, financial condition or liquidity will ultimately be impacted. Given the dynamic nature of these circumstances, the related financial effect cannot be reasonably estimated at this time but is not expected to materially adversely impact our business. See “Part I, Item 1A Risk Factors—The COVID-19 pandemic could negatively affect our operations, business and financial condition, and our liquidity could also be negatively impacted, particularly if the U.S. economy remains unstable for a significant amount of time” of our Annual Report on Form 10-K for the period ended December 31, 2019, filed on August 10, 2020.

In recognition of the significant threat to the liquidity of financial markets posed by the COVID-19 pandemic, the Federal Reserve and Congress have taken dramatic actions to provide liquidity to businesses and the banking system in the U.S. For example, on March 27, 2020, the President signed into law the CARES Act, a sweeping stimulus bill intended to bolster the U.S. economy. On April 24, 2020, the Paycheck Protection Program and Health Care Enhancement Act (“PPPHCE Act”) was enacted, an expansion of the CARES Act. Together, the CARES Act and the PPPHCE Act authorize $175 billion in funding to be distributed to health care providers through the Relief Fund. This funding is intended to support healthcare providers by reimbursing them for healthcare-related expenses or lost revenues attributable to COVID-19. In addition to relief funding, the CARES Act includes temporary changes to Medicare and Medicaid payment rules and relief from certain accounting provisions. There can be no assurance that these governmental interventions will ultimately be successful or that any future interventions will prove successful, and the financial markets may experience significant contractions in available liquidity. In April 2020, we received grants in an aggregate principal amount of $6.9 million, for which we did not apply, from the Relief Fund as part of the automatic general distributions by HHS. The Company returned these funds in June 2020. While we may receive further financial, tax or other relief and other benefits under and as a result of the CARES Act, the PPPHCE Act and other stimulus measures, it is not possible to estimate at this time the need, availability, extent or impact of any such relief.

Acquisitions

In addition to our organic growth, we have grown through acquisitions that have expanded our presence in current markets or facilitated our entry into new markets where in-home care has been moving to managed care organizations.

On June 1, 2019, we completed the acquisition of VIP for approximately $29.9 million. With the purchase of VIP, we expanded our personal care services in the state of New York and into the New York City metropolitan area. We funded this acquisition through the delayed draw term loan portion of our credit facility and cash on hand.

On August 1, 2019, we completed the acquisition of Alliance for approximately $23.5 million. Additionally, we acquired the assets of Foremost Home Care (“Foremost”) for approximately $1.4 million. We funded these acquisitions through a combination of our revolving credit facility and available cash. With the purchase of Alliance, we expanded our personal care, home health and hospice operations in the state of New Mexico. The addition of Foremost will support our growth strategy in the New York City market area.

On October 1, 2019, we completed the acquisition of Hospice Partners for approximately $135.6 million. We funded the acquisition with a portion of the net proceeds of our Public Offering. With the purchase of Hospice Partners, we expanded our hospice operations through 21 locations in Idaho, Kansas, Missouri, Oregon, Texas and Virginia. Hospice Partners also launched a palliative care program in Texas in 2018.

On July 1, 2020, we completed the acquisition of A Plus for approximately $12.2 million plus the amount of excess cash held by A Plus at closing (approximately $2.8 million), with funding provided by cash on hand. With the purchase of A Plus, we expanded our personal care services in the state of Montana.

On November 1, 2020, we completed the acquisition of County Homemakers for approximately $14.6 million, with funding provided by cash on hand. With the purchase of County Homemakers, we expanded our personal care services in the state of Pennsylvania. The Company is currently assessing the fair value of identifiable net assets acquired.

24

Table of Contents

Revenue by Payor and Significant States

Our payor clients are principally federal, state and local governmental agencies and managed care organizations. The federal, state and local programs under which the agencies operate are subject to legislative, budgetary and other risks that can influence reimbursement rates. We are experiencing a transition of business from government payors to managed care organizations, which we believe aligns with our emphasis on coordinated care and the reduction of the need for acute care.

For the three and nine months ended September 30, 2020 and 2019, our revenue by payor and significant states by segment were as follows:

|  | Personal Care |  |
|  | For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30, |  |
|  | 2020 |  |  |  | 2019 |  |  |  | 2020 |  |  |  | 2019 |  |
|  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |
State, local and other governmental programs |  | $ | 85,344 |  |  |  | 51.5 |  | % |  | $ | 75,176 |  |  |  | 48.9 |  | % |  | $ | 242,751 |  |  |  | 50.3 |  | % |  | $ | 221,450 |  |  |  | 52.8 |  | %
Managed care organizations |  |  | 71,700 |  |  |  | 43.2 |  |  |  |  | 68,438 |  |  |  | 44.5 |  |  |  |  | 213,087 |  |  |  | 44.1 |  |  |  |  | 170,004 |  |  |  | 40.6 |  |
Private pay |  |  | 5,193 |  |  |  | 3.1 |  |  |  |  | 5,720 |  |  |  | 3.7 |  |  |  |  | 15,449 |  |  |  | 3.2 |  |  |  |  | 15,912 |  |  |  | 3.8 |  |
Commercial insurance |  |  | 2,498 |  |  |  | 1.5 |  |  |  |  | 2,683 |  |  |  | 1.8 |  |  |  |  | 7,468 |  |  |  | 1.5 |  |  |  |  | 6,569 |  |  |  | 1.6 |  |
Other |  |  | 1,181 |  |  |  | 0.7 |  |  |  |  | 1,736 |  |  |  | 1.1 |  |  |  |  | 4,094 |  |  |  | 0.9 |  |  |  |  | 5,189 |  |  |  | 1.2 |  | %
Total personal care segment net service revenues |  | $ | 165,916 |  |  |  | 100.0 |  | % |  | $ | 153,753 |  |  |  | 100.0 |  | % |  | $ | 482,849 |  |  |  | 100.0 |  | % |  | $ | 419,124 |  |  |  | 100.0 |  |

|  | Hospice |  |
|  | For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30, |  |
|  | 2020 |  |  |  | 2019 |  |  |  | 2020 |  |  |  | 2019 |  |
|  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |
Medicare |  | $ | 22,404 |  |  |  | 93.4 |  | % |  | $ | 10,045 |  |  |  | 92.4 |  | % |  | $ | 68,372 |  |  |  | 92.8 |  | % |  | $ | 25,243 |  |  |  | 92.7 |  | %
Managed care organizations |  |  | 1,130 |  |  |  | 4.7 |  |  |  |  | 584 |  |  |  | 5.4 |  |  |  |  | 3,710 |  |  |  | 5.0 |  |  |  |  | 1,419 |  |  |  | 5.2 |  |
Other |  |  | 452 |  |  |  | 1.9 |  |  |  |  | 245 |  |  |  | 2.2 |  |  |  |  | 1,641 |  |  |  | 2.2 |  |  |  |  | 566 |  |  |  | 2.1 |  |
Total hospice segment net service revenues |  | $ | 23,986 |  |  |  | 100.0 |  | % |  | $ | 10,874 |  |  |  | 100.0 |  | % |  | $ | 73,723 |  |  |  | 100.0 |  | % |  | $ | 27,228 |  |  |  | 100.0 |  | %
New Mexico |  | $ | 10,979 |  |  |  | 45.8 |  | % |  | $ | 10,874 |  |  |  | 100.0 |  | % |  | $ | 33,431 |  |  |  | 45.3 |  | % |  | $ | 27,228 |  |  |  | 100.0 |  | %
All other states |  |  | 13,007 |  |  |  | 54.2 |  |  |  |  | — |  |  |  | — |  |  |  |  | 40,292 |  |  |  | 54.7 |  |  |  |  | — |  |  |  | — |  |
Total hospice segment net service revenues |  | $ | 23,986 |  |  |  | 100.0 |  | % |  | $ | 10,874 |  |  |  | 100.0 |  | % |  | $ | 73,723 |  |  |  | 100.0 |  | % |  | $ | 27,228 |  |  |  | 100.0 |  | %

|  | Home Health |  |
|  | For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30, |  |
|  | 2020 |  |  |  | 2019 |  |  |  | 2020 |  |  |  | 2019 |  |
|  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |
Medicare |  | $ | 3,188 |  |  |  | 78.0 |  | % |  | $ | 3,338 |  |  |  | 76.5 |  | % |  | $ | 9,667 |  |  |  | 79.2 |  | % |  | $ | 7,948 |  |  |  | 79.0 |  | %
Managed care organizations |  |  | 829 |  |  |  | 20.3 |  |  |  |  | 959 |  |  |  | 22.0 |  |  |  |  | 2,325 |  |  |  | 19.0 |  |  |  |  | 1,872 |  |  |  | 18.6 |  |
Other |  |  | 68 |  |  |  | 1.7 |  |  |  |  | 69 |  |  |  | 1.5 |  |  |  |  | 215 |  |  |  | 1.8 |  |  |  |  | 243 |  |  |  | 2.4 |  |
Total Home Health segment net service revenues |  | $ | 4,085 |  |  |  | 100.0 |  | % |  | $ | 4,366 |  |  |  | 100.0 |  | % |  | $ | 12,207 |  |  |  | 100.0 |  | % |  | $ | 10,063 |  |  |  | 100.0 |  | %
New Mexico |  | $ | 4,085 |  |  |  | 100.0 |  | % |  | $ | 4,366 |  |  |  | 100.0 |  | % |  | $ | 12,207 |  |  |  | 100.0 |  | % |  | $ | 10,063 |  |  |  | 100.0 |  | %
Total Home Health segment net service revenues |  | $ | 4,085 |  |  |  | 100.0 |  | % |  | $ | 4,366 |  |  |  | 100.0 |  | % |  | $ | 12,207 |  |  |  | 100.0 |  | % |  | $ | 10,063 |  |  |  | 100.0 |  | %

25

Table of Contents

|  | Personal Care |  |
|  | For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30, |  |
|  | 2020 |  |  |  | 2019 |  |  |  | 2020 |  |  |  | 2019 |  |
|  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |  |  | Amount (in Thousands) |  |  | % of Segment Net Service Revenues |  |
Illinois |  | $ | 74,448 |  |  |  | 44.9 |  | % |  | $ | 61,633 |  |  |  | 40.1 |  | % |  | $ | 215,047 |  |  |  | 44.6 |  | % |  | $ | 178,449 |  |  |  | 42.5 |  | %
New York |  |  | 28,381 |  |  |  | 17.1 |  |  |  |  | 34,730 |  |  |  | 22.6 |  |  |  |  | 87,463 |  |  |  | 18.1 |  |  |  |  | 75,330 |  |  |  | 18.0 |  |
New Mexico |  |  | 21,878 |  |  |  | 13.2 |  |  |  |  | 19,559 |  |  |  | 12.7 |  |  |  |  | 64,402 |  |  |  | 13.3 |  |  |  |  | 54,701 |  |  |  | 13.1 |  |
All other states |  |  | 41,209 |  |  |  | 24.8 |  |  |  |  | 37,831 |  |  |  | 24.6 |  |  |  |  | 115,937 |  |  |  | 24.0 |  |  |  |  | 110,644 |  |  |  | 26.4 |  |
Total personal care segment net service revenues |  | $ | 165,916 |  |  |  | 100.0 |  | % |  | $ | 153,753 |  |  |  | 100.0 |  | % |  | $ | 482,849 |  |  |  | 100.0 |  | % |  | $ | 419,124 |  |  |  | 100.0 |  | %

We derive a significant amount of our net service revenues in Illinois, which represented 38.5% and 36.4% of our net service revenues for the three months ended September 30, 2020 and 2019, respectively, and accounted for 37.8% and 39.1% of our net service revenues for the nine months ended September 30, 2020 and 2019, respectively.

A significant amount of our revenue is derived from one payor client, the Illinois Department on Aging, the largest payor program for our Illinois personal care operations, which accounted for 22.9% and 22.1% of our net service revenues for the three months ended September 30, 2020 and 2019, respectively, and accounted for 23.1% and 26.0% of the Company’s net service revenues for the nine months ended September 30, 2020 and 2019, respectively. The Illinois Department on Aging’s payments for non-Medicaid consumers have been delayed in the past and may continue to be delayed in the future due to budget disputes. The state of Illinois did not adopt comprehensive budgets for fiscal years 2016 or 2017, ended June 30, 2016 and June 30, 2017, respectively. On July 6, 2017, the state of Illinois passed a budget for the state fiscal year 2018, which began on July 1, 2017, authorizing the Illinois Department on Aging to pay for our services rendered to non-Medicaid consumers provided in prior fiscal years. On June 4, 2018, the state of Illinois passed a budget for state fiscal year 2019, which began on July 1, 2018. On June 6, 2019, the state of Illinois passed a budget for state fiscal year 2020, which began on July 1, 2019. On June 10, 2020, the state of Illinois passed a budget for the state fiscal year 2021, which will take effect July 1, 2020. In December 2014, the Chicago City Council passed an ordinance that, over a period of years, raised the minimum wage for Chicago workers, resulting in an increase equal to $13 per hour on July 1, 2019, with increases adjusted based on the Consumer Price Index in subsequent years. On November 26, 2019, the Chicago City Council voted to approve additional increases in the Chicago minimum wage to $14 per hour beginning July 1, 2020 and to $15 per hour beginning July 1, 2021.

The State of Illinois finalized its fiscal year 2020 budget with the inclusion of an appropriation to raise in-home care rates to offset the costs of previous minimum wage increases in Chicago and other areas of the state that were imposed beginning on July 1, 2018. These rates were originally set to be effective July 1, 2019, with in-home care rates to be initially increased by 10.9% to $20.28 from $18.29 to partially offset the costs of the minimum wage hikes. Rates were then further increased on January 1, 2020 by an additional 7.7% to $21.84, providing full funding for both the Chicago minimum wage increases and a statewide raise for all current in-home caregivers.

On November 15, 2019, the State of Illinois received and announced official CMS approval for both rate increases, with the first increase to be effective on December 1, 2019, and the second increase to be effective on January 1, 2020. In addition, the Illinois Department on Aging, in conjunction with Illinois’ Health Care and Family Services, announced that the new rates would become effective retroactive to July 1, 2019 for services covered by managed care organizations. On January 15, 2020, the Department on Aging announced confirmation that a one-time bonus payment would be paid to providers who have provided services to clients not enrolled in a managed care organization, for the time period of July 1, 2019 through November 30, 2019 using an updated hourly rate of $20.28. The bonus payment of $6.8 million was recognized as net service revenues as of December 31, 2019.

On June 10, 2020, the State of Illinois finalized its fiscal year 2021 budget, with in-home care rates to be increased by 7.1% to $23.40 from $21.84, effective January 1, 2021, contingent upon federal CMS approval.

Our business will benefit from the rate increases noted above, but there is no assurance that additional offsetting rate increases will be adopted in Illinois for fiscal years beyond fiscal year 2020, and our financial performance will be adversely impacted for any periods in which an additional offsetting reimbursement rate increase is not in effect.

Impact of Changes in Medicare and Medicaid Reimbursement

Home Health

In June 2019, CMS began the Review Choice Demonstration for Home Health Services demonstration in Illinois to identify and prevent fraud, reduce the number of Medicare appeals, and improve provider compliance with Medicare program requirements. The Review Choice Demonstration began phasing in home health agencies in Ohio and Texas in August 2018 and January 2020, respectively. Home health agencies may initially select from the following claims review and approval processes: pre-claim review, post-payment review, or a minimal post-payment review with a 25% payment reduction. Home health agencies that maintain high compliance levels will be eligible for additional, less burdensome options. In March 2020, CMS paused certain claims processing requirements for the Review Choice Demonstration due to the COVID-19 pandemic. CMS announced that it would discontinue exercising enforcement discretion beginning in August 2020, regardless of the status of the public health emergency, and also began phasing in home health agencies in North Carolina and Florida. Following the resumption of the demonstration, MACs will conduct post-payment review on claims that were submitted and paid during the pause. We are currently unable to predict what impact, if any, this program may have on our result of operations or financial position.

26

Table of Contents

Home health services provided to Medicare beneficiaries are paid under the Medicare Home Health Prospective Payment System (“HHPPS”). Historically, the HHPPS was based on 60-day episodes of care and used a case-mix system that relied on the num ber of visits to determine payment. Effective January 1, 2020, CMS began using a 30-day episode of care for home health payments and implemented the Patient-Driven Groupings Model (“PDGM”) as part of the shift toward value-based care. The PDGM classifies p atients based on clinical characteristics and other patient information into payment categories and eliminates the use of therapy service thresholds. Also effective January 1, 2020, CMS finalized a policy allowing therapy assistants to provide maintenance therapy services in the home and modified certain requirements relating to the home health plan of care.

CMS updates the HHPPS payment rates each calendar year. Effective January 1, 2020, HHPPS rates increased by 1.3%, which reflects a 1.5% payment update as mandated by the Bipartisan Budget Act of 2018, offset by a 0.2 percentage point decrease in payments to home health agencies due to changes in the rural add-on percentages also mandated by the Bipartisan Budget Act of 2018, among other adjustments. CMS requires both home health and hospice providers to submit quality reporting data each year. Home health providers that do not comply are subject to a 2 percentage point reduction to their market basket update.

Historically, CMS has paid home health providers 50% to 60% of anticipated payment at the beginning of a patient’s care episode through a request for anticipated payment (“RAP”). However, to address potential program integrity risks, CMS is currently phasing out RAP payments. For calendar year 2020, CMS reduced RAP payments to 20% of the anticipated payment and limited those payments to existing home health providers. In calendar year 2021, CMS will not provide any up-front payments in response to a RAP but will continue to require home health providers to submit streamlined RAPs as notice that a beneficiary is under a home health period of care. CMS will further reduce the administrative burden on providers in calendar year 2022, replacing the RAP with a “Notice of Admission.”

Hospice

Hospice services provided to Medicare beneficiaries are paid under the Medicare Hospice Prospective Payment System, under which CMS sets a daily rate for each day a patient is enrolled in the hospice benefit. CMS updates these rates each fiscal year. Effective October 1, 2020, CMS increased hospice payment rates by 2.4%. This reflected a 2.4% market basket increase reduced by the multifactor productivity adjustment of 0.04 percentage points as required by the ACA. Additionally, the aggregate cap, which limits the total Medicare reimbursement that a hospice may receive based on an annual per-beneficiary cap amount and the number of Medicare patients served, was updated to $30,683.93 for fiscal year 2021. This amount reflects the hospice payment update of 2.4%. If a hospice’s Medicare payments exceed its aggregate cap, it must repay Medicare the excess amount.

COVID-19 Relief

As a result of the COVID-19 pandemic, federal and state governments have passed legislation, promulgated regulations, and taken other administrative actions intended to assist healthcare providers in providing care to COVID-19 patients and other patients during the public health emergency. These temporary measures include relief from Medicare conditions of participation requirements for healthcare providers, relaxation of licensure requirements for healthcare professionals, relaxation of privacy restrictions for telehealth remote communications, promoting use of telehealth by expanding the scope of services for which Medicare reimbursement is available, and limited waivers of fraud and abuse laws for activities related to COVID-19 during the emergency period. The current federal public health emergency declaration expires January 21, 2021. The HHS Secretary may renew the declaration for successive 90-day periods for as long as the emergency continues to exist and may terminate the declaration whenever he determines that the emergency no longer exists.

One of the primary sources of relief for healthcare providers is the CARES Act, which was expanded by the PPPHCE Act. Together, the CARES Act and the PPPHCE Act include $175 billion in funding to be distributed through the Relief Fund to eligible providers, including public entities and Medicare- and/or Medicaid-enrolled providers. Relief Fund payments are intended to compensate healthcare providers for lost revenues and health care related expenses incurred in response to the COVID-19 pandemic and are not required to be repaid, provided that recipients attest to and comply with certain terms and conditions, including limitations on balance billing and not using funds received from the Relief Fund to reimburse expenses or losses that other sources are obligated to reimburse. In April 2020, the Company received grants in an aggregate principal amount of $6.9 million, for which it did not apply, from the Relief Fund as part of the automatic general distributions by HHS. The Company returned these funds in June 2020.

In addition, the CARES Act expands the Medicare Accelerated and Advance Payment Program to increase cash flow to providers impacted by the COVID-19 pandemic. Hospice and home health providers were able to request an advance or accelerated payment of up to 100% of the Medicare payment amount for a three-month period (not including Medicare Advantage payments). Effective October 8, 2020, CMS is no longer accepting applications for accelerated or advance payments. The Medicare Accelerated and Advanced Payment Program payments are a loan that providers must pay back. Recoupment of these payments was due to begin in August, but CMS has delayed the recoupment process for these payments, based on amended repayment terms imposed by the Continuing Appropriations Act, 2021 and Others Extension Act, enacted October 1, 2020, until one year after payment was issued. Beginning one year from the date payment was issued and continuing for eleven months, Medicare payments owed to providers and suppliers will be recouped at a rate of 25%. After the eleven months end, Medicare payments owed to providers and suppliers will be recouped at a rate of 50% for another six months. After the six months end, a letter for any remaining balance will be issued. If the remaining balance is not paid within thirty days, interest will accrue at a rate of 4%.

The CARES Act also includes other provisions offering financial relief, for example temporarily lifting the Medicare sequester from May 1 through December 31, 2020, which would have otherwise reduced payments to Medicare providers by 2% (but also extending sequestration through 2030). The Medicare sequester relief resulted in an increase of $0.1 million and $0.2 million, respectively, to home health net service

27

Table of Contents

revenues and $0.5 milli on and $0.8 million to hospice net service revenues, respectively, for the three and nine months ended September 30, 2020.

Due to the recent enactment of the CARES Act, the PPPHCE Act and other enacted legislation, there is still a high degree of uncertainty surrounding their implementation. Further, the federal government is considering additional stimulus measures, federal agencies continue to issue related regulations and guidance, and the public health emergency continues to evolve. We continue to assess the potential impact of the CARES Act, the PPPHCE Act and other laws, regulations, and guidance related to COVID-19 on our business, results of operations, financial condition and cash flows.

Components of our Statements of Income

Net Service Revenues

We generate net service revenues by providing our services directly to consumers and primarily on an hourly basis. We receive payment for providing such services from our payor clients, including federal, state and local governmental agencies, managed care organizations, commercial insurers and private consumers. Net service revenues are principally provided based on authorized hours, determined by the relevant agency, at an hourly rate which is either contractual or fixed by legislation and are recognized at the time services are rendered. We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.

Cost of Service Revenues

We incur direct care wages, payroll taxes and benefit-related costs in connection with providing our services. We also provide workers’ compensation and general liability coverage for our employees.

Employees are also reimbursed for their travel time and related travel costs in certain instances.

General and Administrative Expenses

Our general and administrative expenses include our costs for operating our network of local agencies and our administrative offices. Our agency expenses consist of costs for supervisory personnel, our community care supervisors and office administrative costs. Personnel costs include wages, payroll taxes and employee benefits. Facility costs include rents, utilities, and postage, telephone and office expenses. Our support center expenses include costs for accounting, information systems, human resources, billing and collections, contracting, marketing and executive leadership. These expenses consist of compensation, including stock-based compensation, payroll taxes, employee benefits, legal, accounting and other professional fees, travel, general insurance, rents, provision for doubtful accounts and related facility costs. Expenses related to streamlining our operations such as costs related to terminated employees, termination of professional services relationships, other contract termination costs and asset write-offs are also included in general and administrative expenses.

Depreciation and Amortization Expenses

Depreciable assets consist principally of furniture and equipment, network administration and telephone equipment, and operating system software. Depreciable and leasehold assets are depreciated or amortized on a straight-line method over their useful lives or, if less and if applicable, their lease terms. We amortize our intangible assets with finite lives, consisting of customer and referral relationships, trade names, trademarks and non-competition agreements, principally using accelerated methods based upon their estimated useful lives.

Interest Expense

Interest expense is reported in the Unaudited Condensed Consolidated Statements of Income when incurred and consists of (i) interest and unused credit line fees on our credit facility and (ii) interest on our financing lease obligations.

Income Tax Expense

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. For the three and nine months ended September 30, 2020 and 2019, the federal statutory rate was 21.0%. The effective income tax rate was 23.6% and 24.4% for the three months ended September 30, 2020 and 2019, respectively. For the three months ended September 30, 2020 and 2019, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes and non-deductible compensation, partially offset by an excess tax benefit and the use of federal employment tax credits.

The effective income tax rates are 20.5% and 21.3% for the nine months ended September 30, 2020 and 2019, respectively. For the nine months ended September 30, 2020 and 2019, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of an excess tax benefit and the use of federal employment tax credits, partially offset by state taxes and non-deductible compensation. The excess tax benefit is a discrete item, related to the vesting of equity shares, which requires us to recognize the benefit fully in the period. An excess tax benefit results if the Company’s income tax deduction exceeds the cumulative costs of the award recognized on the Unaudited Condensed Consolidated Statements of Income.

28

Table of Contents

Results of Operations — Consolidated

Three Months Ended September 30, 2020 Compared to Three Months Ended September 30, 2019

The following table sets forth, for the periods indicated, our unaudited condensed consolidated results of operations.

|  | For the Three Months Ended September 30, |  |  |  |  |  |  |  |  |  |  |
|  | 2020 |  |  |  | 2019 |  |  |  | Change |  |
|  |  |  |  |  | % Of |  |  |  |  |  |  |  | % Of |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  | Net Service |  |  |  |  |  |  |  | Net Service |  |  |  |  |  |  |  |  |  |  |
|  | Amount |  |  | Revenues |  |  |  | Amount |  |  | Revenues |  |  |  | Amount |  |  | % |  |
|  | (Amounts in Thousands, Except Percentages) |  |
Net service revenues |  | $ | 193,987 |  |  |  | 100.0 |  | % |  | $ | 168,993 |  |  |  | 100.0 |  | % |  | $ | 24,994 |  |  |  | 14.8 |  | %
Cost of service revenues |  |  | 137,686 |  |  |  | 71.0 |  |  |  |  | 123,817 |  |  |  | 73.3 |  |  |  |  | 13,869 |  |  |  | 11.2 |  |
Gross profit |  |  | 56,301 |  |  |  | 29.0 |  |  |  |  | 45,176 |  |  |  | 26.7 |  |  |  |  | 11,125 |  |  |  | 24.6 |  |
General and administrative expenses |  |  | 40,733 |  |  |  | 21.0 |  |  |  |  | 35,085 |  |  |  | 20.8 |  |  |  |  | 5,648 |  |  |  | 16.1 |  |
Depreciation and amortization |  |  | 3,045 |  |  |  | 1.6 |  |  |  |  | 2,756 |  |  |  | 1.6 |  |  |  |  | 289 |  |  |  | 10.5 |  |
Total operating expenses |  |  | 43,778 |  |  |  | 22.6 |  |  |  |  | 37,841 |  |  |  | 22.4 |  |  |  |  | 5,937 |  |  |  | 15.7 |  |
Operating income from continuing operations |  |  | 12,523 |  |  |  | 6.4 |  |  |  |  | 7,335 |  |  |  | 4.3 |  |  |  |  | 5,188 |  |  |  | 70.7 |  |
Interest income |  |  | (87 | ) |  |  | — |  |  |  |  | (786 | ) |  |  | (0.5 | ) |  |  |  | 699 |  |  |  | (88.9 | ) |
Interest expense |  |  | 680 |  |  |  | 0.3 |  |  |  |  | 866 |  |  |  | 0.5 |  |  |  |  | (186 | ) |  |  | (21.5 | ) |
Total interest expense, net |  |  | 593 |  |  |  | 0.3 |  |  |  |  | 80 |  |  |  | — |  |  |  |  | 513 |  |  |  | 641.3 |  |
Income from continuing operations before income taxes |  |  | 11,930 |  |  |  | 6.1 |  |  |  |  | 7,255 |  |  |  | 4.3 |  |  |  |  | 4,675 |  |  |  | 64.4 |  |
Income tax expense |  |  | 2,811 |  |  |  | 1.4 |  |  |  |  | 1,769 |  |  |  | 1.1 |  |  |  |  | 1,042 |  |  |  | 58.9 |  |
Net income from continuing operations |  |  | 9,119 |  |  |  | 4.7 |  |  |  |  | 5,486 |  |  |  | 3.2 |  |  |  |  | 3,633 |  |  |  | 66.2 |  |
Net loss from discontinued operations |  |  | — |  |  |  | — |  |  |  |  | (574 | ) |  |  | (0.3 | ) |  |  |  | 574 |  |  |  | (100.0 | ) |
Net income |  | $ | 9,119 |  |  |  | 4.7 |  | % |  | $ | 4,912 |  |  |  | 2.9 |  | % |  | $ | 4,207 |  |  |  | 85.6 |  | %

Net service revenues increased by 14.8% to $194.0 million for the three months ended September 30, 2020 compared to $169.0 million for the three months ended September 30, 2019. The increase was due to an increase in same store growth of 4.8% and a 7.7% increase in revenues per billable hour for the three months ended September 30, 2020, partially offset by a decrease in average billable census of 1.9% in our personal care segment. In addition, revenue increased by $13.1 million from our hospice segment during the three months ended September 30, 2020, compared to the same period in 2019, partially attributed to the fiscal year 2019 acquisitions of Hospice Partners and Alliance.

Gross profit, expressed as a percentage of net service revenues, increased to 29.0% for the three months ended September 30, 2020, compared to 26.7% for the same period in 2019. The increase was mainly attributed to the acquisition of the relatively higher margin businesses in 2019.

General and administrative expenses increased to $40.7 million for the three months ended September 30, 2020 as compared to $35.1 million for the three months ended September 30, 2019. The increase in general and administrative expenses was primarily due to acquisitions that resulted in an increase in administrative employee wages, taxes and benefit costs of $5.3 million, an increase in data processing of $0.4 million and an increase in rent expense of $0.3 million. In addition, professional fees increased by $1.0 million for the three months ended September 30, 2020 compared to the three months ended September 30, 2019, partially offset by a decrease in acquisition related costs of $1.6 million for the three months ended September 30, 2020 compared to the three months ended September 30, 2019. General and administrative expenses, expressed as a percentage of net service revenues increased to 21.0% for the three months ended September 30, 2020, from 20.8% for the three months ended September 30, 2019.

Depreciation and amortization expense increased to $3.0 million from $2.8 million for the three months ended September 30, 2020 and 2019, respectively, primarily due to the increase of intangible assets related to the fiscal year 2019 acquisitions.

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. For the three months ended September 30, 2020 and 2019, the federal statutory rate was 21.0%. The effective income tax rate was 23.6% and 24.4% for the three months ended September 30, 2020 and 2019, respectively. For the three months ended September 30, 2020 and 2019, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of state taxes and non-deductible compensation, partially offset by an excess tax benefit and the use of federal employment tax credits.

29

Table of Contents

Nine Months Ended September 30, 20 20 Compared to Nine Months Ended September 30, 2019

The following table sets forth, for the periods indicated, our consolidated results of operations.

|  | For the Nine Months Ended September 30, |  |  |  |  |  |  |  |  |  |  |
|  | 2020 |  |  |  | 2019 |  |  |  | Change |  |
|  |  |  |  |  | % Of |  |  |  |  |  |  |  | % Of |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  |  | Net Service |  |  |  |  |  |  |  | Net Service |  |  |  |  |  |  |  |  |  |  |
|  | Amount |  |  | Revenues |  |  |  | Amount |  |  | Revenues |  |  |  | Amount |  |  | % |  |
|  | (Amounts in Thousands, Except Percentages) |  |
Net service revenues |  | $ | 568,779 |  |  |  | 100.0 |  | % |  | $ | 456,415 |  |  |  | 100.0 |  | % |  | $ | 112,364 |  |  |  | 24.6 |  | %
Cost of service revenues |  |  | 401,646 |  |  |  | 70.6 |  |  |  |  | 334,719 |  |  |  | 73.3 |  |  |  |  | 66,927 |  |  |  | 20.0 |  |
Gross profit |  |  | 167,133 |  |  |  | 29.4 |  |  |  |  | 121,696 |  |  |  | 26.7 |  |  |  |  | 45,437 |  |  |  | 37.3 |  |
General and administrative expenses |  |  | 125,470 |  |  |  | 22.0 |  |  |  |  | 94,109 |  |  |  | 20.7 |  |  |  |  | 31,361 |  |  |  | 33.3 |  |
Depreciation and amortization |  |  | 8,872 |  |  |  | 1.6 |  |  |  |  | 7,365 |  |  |  | 1.6 |  |  |  |  | 1,507 |  |  |  | 20.5 |  |
Total operating expenses |  |  | 134,342 |  |  |  | 23.6 |  |  |  |  | 101,474 |  |  |  | 22.3 |  |  |  |  | 32,868 |  |  |  | 32.4 |  |
Operating income from continuing operations |  |  | 32,791 |  |  |  | 5.8 |  |  |  |  | 20,222 |  |  |  | 4.4 |  |  |  |  | 12,569 |  |  |  | 62.2 |  |
Interest income |  |  | (576 | ) |  |  | (0.1 | ) |  |  |  | (1,096 | ) |  |  | (0.2 | ) |  |  |  | 520 |  |  |  | (47.4 | ) |
Interest expense |  |  | 2,309 |  |  |  | 0.4 |  |  |  |  | 2,164 |  |  |  | 0.4 |  |  |  |  | 145 |  |  |  | 6.7 |  |
Total interest expense, net |  |  | 1,733 |  |  |  | 0.3 |  |  |  |  | 1,068 |  |  |  | 0.2 |  |  |  |  | 665 |  |  |  | 62.3 |  |
Income from continuing operations before income taxes |  |  | 31,058 |  |  |  | 5.5 |  |  |  |  | 19,154 |  |  |  | 4.2 |  |  |  |  | 11,904 |  |  |  | 62.1 |  |
Income tax expense |  |  | 6,374 |  |  |  | 1.2 |  |  |  |  | 4,080 |  |  |  | 0.9 |  |  |  |  | 2,294 |  |  |  | 56.2 |  |
Net income from continuing operations |  |  | 24,684 |  |  |  | 4.3 |  |  |  |  | 15,074 |  |  |  | 3.3 |  |  |  |  | 9,610 |  |  |  | 63.8 |  |
Net loss from discontinued operations |  |  | — |  |  |  | — |  |  |  |  | (574 | ) |  |  | (0.1 | ) |  |  |  | 574 |  |  |  | (100.0 | ) |
Net income |  | $ | 24,684 |  |  |  | 4.3 |  | % |  | $ | 14,500 |  |  |  | 3.2 |  |  |  | $ | 10,184 |  |  |  | 70.2 |  | %

Net service revenues increased by 24.6% to $568.8 million for the nine months ended September 30, 2020 compared to $456.4 million for the nine months ended September 30, 2019. The increase was due to an increase in same store growth of 8.8% and a 10.4 % increase in revenues per billable hour for the nine months ended September 30, 2020, partially offset by a decrease in average billable census of 2.1% in our personal care segment. In addition, revenue increased by $46.5 million from our hospice segment during the nine months ended September 30, 2020, compared to the same period in 2019, attributed to the fiscal year 2019 acquisitions of Hospice Partners and Alliance.

Gross profit, expressed as a percentage of net service revenues, increased to 29.4% for the nine months ended September 30, 2020, compared to 26.7% for the same period in 2019. The increase was mainly attributed to the acquisition of the relatively higher margin businesses in 2019.

General and administrative expenses increased to $125.5 million for the nine months ended September 30, 2020 as compared to $94.1 million for the nine months ended September 30, 2019. The increase in general and administrative expenses was primarily due to acquisitions that resulted in an increase in administrative employee wages, taxes and benefit costs of $21.5 million, an increase in data processing of $1.7 million and an increase in rent expense of $1.6 million. In addition, professional fees increased by $3.4 million for the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019. General and administrative expenses, expressed as a percentage of net service revenues increased to 22.0% for the nine months ended September 30, 2020, from 20.7% for the nine months ended September 30, 2019.

Depreciation and amortization expense increased to $8.9 million from $7.4 million for the nine months ended September 30, 2020 and 2019, respectively, primarily due to the increase of intangible assets related to the fiscal year 2019 acquisitions.

All of our income is from domestic sources. We incur state and local taxes in states in which we operate. For the nine months ended September 30, 2020 and 2019, the federal statutory rate was 21.0%. The effective income tax rate was 20.5% and 21.3% for the nine months ended September 30, 2020 and 2019, respectively.

For the nine months ended September 30, 2020 and 2019, the difference between our federal statutory and effective income tax rates was principally due to the inclusion of an excess tax benefit and the use of federal employment tax credits, partially offset by state taxes and non-deductible compensation. The excess tax benefit is a discrete item, related to the vesting of equity shares, which requires us to recognize the benefit fully in the period.

30

Table of Contents

Results of Operations – Segments

The following tables and related analysis summarize our operating results and business metrics by segment:

Personal Care Segment

|  | For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30, |  |
|  | 2020 |  |  |  | 2019 |  |  |  | Change |  |  |  | 2020 |  |  |  | 2019 |  |  |  | Change |  |
Personal Care Segment |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % |  |  |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % |  |
|  | (Amounts in Thousands, Except Percentages) |  |  |  | (Amounts in Thousands, Except Percentages) |  |
Operating Results |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net service revenues |  | $ | 165,916 |  |  |  | 100.0 |  | % |  | $ | 153,753 |  |  |  | 100.0 |  | % |  | $ | 12,163 |  |  |  | 7.9 |  | % |  | $ | 482,849 |  |  |  | 100.0 |  | % |  | $ | 419,124 |  |  |  | 100.0 |  | % |  | $ | 63,725 |  |  |  | 15.2 |  | %
Cost of services revenues |  |  | 124,493 |  |  |  | 75.0 |  |  |  |  | 115,504 |  |  |  | 75.1 |  |  |  |  | 8,989 |  |  |  | 7.8 |  |  |  |  | 359,344 |  |  |  | 74.4 |  |  |  |  | 314,329 |  |  |  | 75.0 |  |  |  |  | 45,015 |  |  |  | 14.3 |  |
Gross profit |  |  | 41,423 |  |  |  | 25.0 |  |  |  |  | 38,249 |  |  |  | 24.9 |  |  |  |  | 3,174 |  |  |  | 8.3 |  |  |  |  | 123,505 |  |  |  | 25.6 |  |  |  |  | 104,795 |  |  |  | 25.0 |  |  |  |  | 18,710 |  |  |  | 17.9 |  |
General and administrative expenses |  |  | 14,837 |  |  |  | 8.9 |  |  |  |  | 14,737 |  |  |  | 9.6 |  |  |  |  | 100 |  |  |  | 0.7 |  |  |  |  | 45,042 |  |  |  | 9.3 |  |  |  |  | 40,053 |  |  |  | 9.6 |  |  |  |  | 4,989 |  |  |  | 12.5 |  |
Segment operating income |  | $ | 26,586 |  |  |  | 16.0 |  | % |  | $ | 23,512 |  |  |  | 15.3 |  | % |  | $ | 3,074 |  |  |  | 13.1 |  | % |  | $ | 78,463 |  |  |  | 16.3 |  | % |  | $ | 64,742 |  |  |  | 15.4 |  | % |  | $ | 13,721 |  |  |  | 21.2 |  | %
Business Metrics (Actual Numbers, Except Billable Hours in Thousands) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Location at period end |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 153 |  |  |  |  |  |  |  |  | 153 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Average billable census * (1) |  |  | 38,589 |  |  |  |  |  |  |  |  | 39,342 |  |  |  |  |  |  |  |  | (753 | ) |  |  | (1.9 | ) | % |  |  | 38,443 |  |  |  |  |  |  |  |  | 39,279 |  |  |  |  |  |  |  |  | (836 | ) |  |  | (2.1 | ) | %
Billable hours * (2) |  |  | 7,778 |  |  |  |  |  |  |  |  | 7,785 |  |  |  |  |  |  |  |  | (7.0 | ) |  |  | (0.1 | ) |  |  |  | 22,825 |  |  |  |  |  |  |  |  | 21,918 |  |  |  |  |  |  |  |  | 907 |  |  |  | 4.1 |  |
Average billable hours per census per month * (2) |  |  | 66.9 |  |  |  |  |  |  |  |  | 65.5 |  |  |  |  |  |  |  |  | 1.4 |  |  |  | 2.1 |  |  |  |  | 65.6 |  |  |  |  |  |  |  |  | 61.5 |  |  |  |  |  |  |  |  | 4.1 |  |  |  | 6.7 |  |
Billable hours per business day * (2) |  |  | 117,841 |  |  |  |  |  |  |  |  | 117,956 |  |  |  |  |  |  |  |  | (115 | ) |  |  | (0.1 | ) |  |  |  | 116,454 |  |  |  |  |  |  |  |  | 112,400 |  |  |  |  |  |  |  |  | 4,054 |  |  |  | 3.6 |  |
Revenues per billable hour * (2) |  | $ | 21.29 |  |  |  |  |  |  |  | $ | 19.76 |  |  |  |  |  |  |  | $ | 1.53 |  |  |  | 7.7 |  | % |  | $ | 21.11 |  |  |  |  |  |  |  | $ | 19.13 |  |  |  |  |  |  |  | $ | 1.98 |  |  |  | 10.4 |  | %
Same store growth revenue % * (3) |  |  | 4.8 |  | % |  |  |  |  |  |  | 7.2 |  | % |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 8.8 |  | % |  |  |  |  |  | 6.3 |  | % |  |  |  |  |  |  |  |  |  |  |  |  |

(1) | Average billable census is the number of unique clients receiving a billable service during the year and is the total census divided by months in operation during the period.

(2) | Billable hours is the total number of hours served to clients during the period. Average billable hours per census per month is billable hours divided by average billable census. Billable hours per day is total billable hours divided by the number of business days in the period. Revenues per billable hour is revenue attributed to billable hours divided by billable hours.

(3) | Same store growth reflects the change in year-over-year revenue for the same store base. We define the same store base to include those stores open for at least 52 full weeks. This measure highlights the performance of existing stores, while excluding the impact of acquisitions, new store openings and closures.

* | Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these, provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly-titled performance indicators used by other companies.

Net service revenues from state, local and other governmental programs accounted for 51.5% and 48.9% of net service revenues for the three months ended September 30, 2020 and 2019, respectively, and 50.3% and 52.8% of net service revenues for the nine months ended September 30, 2020 and 2019, respectively. Managed care organizations accounted for 43.2% and 44.5% of net service revenues for the three months ended September 30, 2020 and 2019, and 44.1% and 40.6% of net service revenues for the nine months ended September 30, 2020 and 2019, respectively, with commercial insurance, private pay and other payors accounting for the remainder of net service revenues. One payor client, the Illinois Department on Aging, accounted for 22.9% and 22.1% of net service revenues for the three months ended September 30, 2020 and 2019, respectively, and accounted for 23.1% and 26.0% of net service revenues for the nine months ended September 30, 2020 and 2019, respectively.

Net service revenues increased by 7.9% for the three months ended September 30, 2020 compared to the three months ended September 30, 2019. Net service revenues increased primarily as a result of an increase in same store growth of 4.8% and an increase in revenues per billable hour of 7.7%, partially offset by a decrease in average billable census of 1.9% for the three months ended September 30, 2020 as compared to the three months ended September 30, 2019. Net service revenues increased by 15.2% for the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019. Net service revenues increased primarily due to a result of an increase in same store growth of 8.8%, an increase in billable hours of 4.1% a nd a 10.4% increase in revenues per billable hour, partially offset by a decrease in average billable census of 2.1% for the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019. Revenue per billable hours increased for the three and nine months ended September 30, 2020 compared to September 30, 2019, mainly attributed to rate increases discussed above.

31

Table of Contents

Gross profit, expressed as a percentage of net service revenues, increased to 25.0% for the three months ended September 30, 2020 from 24.9% for the three months ended September 30, 2019 and from 25.6% for the nine months ended September 30, 2020 to 25.0% for the nine months ended September 30, 2019. This increase was primarily due to a decrease in direct employee wages, taxes and benefit costs as a percentage of net service revenues of 0.1% and 0.9% for the three and nine months ended Septe mber 30, 2020 as compared to the three months ended September 30, 2019.

General and administrative expenses increased by approximately $0.1 million and $5.0 million for the three and nine months ended September 30, 2020, respectively. Administrative employee wages, taxes and benefit costs for the nine months ended September 30, 2020 increased $5.1 million primarily due to acquisitions.

Hospice Segment

|  | For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30, |  |
|  | 2020 |  |  |  | 2019 |  |  |  | Change |  |  |  | 2020 |  |  |  | 2019 |  |  |  | Change |  |
Hospice Segment |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % |  |  |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % |  |
|  | (Amounts in Thousands, Except Percentages) |  |  |  | (Amounts in Thousands, Except Percentages) |  |
Operating Results |  |  |  |  |  |  |  |
Net service revenues |  | $ | 23,986 |  |  |  | 100.0 |  | % |  | $ | 10,874 |  |  |  | 100.0 |  | % |  | $ | 13,112 |  |  |  | 120.6 |  | % |  | $ | 73,723 |  |  |  | 100.0 |  | % |  | $ | 27,228 |  |  |  | 100.0 |  | % |  | $ | 46,495 |  |  |  | 170.8 |  | %
Cost of services revenues |  |  | 10,508 |  |  |  | 43.8 |  |  |  |  | 5,495 |  |  |  | 50.5 |  |  |  |  | 5,013 |  |  |  | 91.2 |  |  |  |  | 33,749 |  |  |  | 45.8 |  |  |  |  | 13,587 |  |  |  | 49.9 |  |  |  |  | 20,162 |  |  |  | 148.4 |  |
Gross profit |  |  | 13,478 |  |  |  | 56.2 |  |  |  |  | 5,379 |  |  |  | 49.5 |  |  |  |  | 8,099 |  |  |  | 150.6 |  |  |  |  | 39,974 |  |  |  | 54.2 |  |  |  |  | 13,641 |  |  |  | 50.1 |  |  |  |  | 26,333 |  |  |  | 193.0 |  |
General and administrative expenses |  |  | 5,904 |  |  |  | 24.6 |  |  |  |  | 1,824 |  |  |  | 16.8 |  |  |  |  | 4,080 |  |  |  | 223.7 |  |  |  |  | 18,658 |  |  |  | 25.3 |  |  |  |  | 4,962 |  |  |  | 18.2 |  |  |  |  | 13,696 |  |  |  | 276.0 |  |
Segment operating income |  | $ | 7,574 |  |  |  | 31.6 |  | % |  | $ | 3,555 |  |  |  | 32.7 |  | % |  | $ | 4,019 |  |  |  | 113.1 |  | % |  | $ | 21,316 |  |  |  | 28.9 |  | % |  | $ | 8,679 |  |  |  | 31.9 |  | % |  | $ | 12,637 |  |  |  | 145.6 |  | %
Business Metrics (Actual Numbers) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Locations at period end |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 30 |  |  |  |  |  |  |  |  | 14 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Admissions * (1) |  |  | 1,399 |  |  |  |  |  |  |  |  | 563 |  |  |  |  |  |  |  |  | 836 |  |  |  | 148.5 |  | % |  |  | 4,393 |  |  |  |  |  |  |  |  | 1,548 |  |  |  |  |  |  |  |  | 2,845 |  |  |  | 183.8 |  | %
Average daily census * (2) |  |  | 1,681 |  |  |  |  |  |  |  |  | 791 |  |  |  |  |  |  |  |  | 890 |  |  |  | 112.5 |  |  |  |  | 1,762 |  |  |  |  |  |  |  |  | 659 |  |  |  |  |  |  |  |  | 1,103 |  |  |  | 167.4 |  |
Average length of stay * (3) |  |  | 109 |  |  |  |  |  |  |  |  | 121 |  |  |  |  |  |  |  |  | (12 | ) |  |  | (9.9 | ) |  |  |  | 103 |  |  |  |  |  |  |  |  | 122 |  |  |  |  |  |  |  |  | (19 | ) |  |  | (15.6 | ) |
Patient days * (4) |  |  | 154,609 |  |  |  |  |  |  |  |  | 72,261 |  |  |  |  |  |  |  |  | 82,348 |  |  |  | 114.0 |  |  |  |  | 482,765 |  |  |  |  |  |  |  |  | 178,792 |  |  |  |  |  |  |  |  | 303,973 |  |  |  | 170.0 |  |
Revenue per patient day * (5) |  | $ | 155.14 |  |  |  |  |  |  |  | $ | 150.48 |  |  |  |  |  |  |  | $ | 4.66 |  |  |  | 3.1 |  | % |  | $ | 152.71 |  |  |  |  |  |  |  | $ | 152.29 |  |  |  |  |  |  |  | $ | 0.42 |  |  |  | 0.3 |  | %

(1) | Represents referral process and new patients on service during the period.

(2) | Average daily census is total patient days divided by the number of days in the period.

(3) | Average length of stay is the average number of days a patient is on service, calculated upon discharge, and is total patient days divided by total discharges in the period.

(4) | Patient days is days of service for all patients in the period.

(5) | Revenue per patient day is hospice revenue divided by the number of patient days in the period.

* | Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these, provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly-titled performance indicators used by other companies.

Hospice generates net service revenues by providing care to patients with a life expectancy of six months or less, and their families. Net service revenues from Medicare accounted for 93.4% and 92.4% and managed care organizations accounted for 4.7% and 5.4% for the three months ended September 30, 2020 and 2019, respectively. Net service revenues from Medicare accounted for 92.8% and 92.7% and managed care organizations accounted for 5.0% and 5.2% for the nine months ended September 30, 2020 and 2019, respectively.

Net service revenues increased by $13.1 million and $46.5 for the three and nine months ended September 30, 2020 compared to the three and nine months ended September 30, 2019. For the three and nine months ended September 30, 2020, net service revenues increased primarily due to an increase in average daily census partially attributed to the acquisitions of Alliance on August 1, 2019 and Hospice Partners on October 1, 2019.

Gross profit, expressed as a percentage of net service revenues was 56.2% and 49.5% for the three months ended September 30, 2020 and 2019, respectively, and 54.2% and 50.1%, for the nine months ended September 30, 2020 and 2019, respectively. For the three months ended September 30, 2020, the increase of gross profit as a percentage of net service revenues was mainly attributed to a decrease of employee wages, taxes and benefit costs of 1.8%, pharmacy costs of 1.2%, medical equipment of 1.1% and direct service supply costs of 0.7%. For the nine months ended September 30, 2020, the increase of gross profit as a percentage of net service revenues was mainly attributed to a decrease in pharmacy costs of 1.0% and medical equipment of 1.0%.

32

Table of Contents

The hospice segment’s general an d administrative expenses primarily consist of administrative employee wages, taxes and benefit costs, rent, information technology and office expenses. General and administrative expenses, expressed as a percentage of net service revenues was 24.6% and 16.8% for the three months ended September 30, 2020 and 2019, respectively, and 25.3% and 18.2% for the nine months ended September 30, 2020 and 2019, respectively. The increase in general and administrative expenses was primarily due to acqu isitions that resulted in a $3.4 million and $11.4 million increase in administrative employee wages, taxes and benefit costs and a $0.3 million and $0.9 million increase in rent expenses for the three and nine months ended September 30, 2020. The hospic e segment’s operating income was $7.6 million and $3.6 million for the three months ended September 30, 2020 and 2019, respectively, and $21.3 million and $8.7 million for the nine months ended September 30, 2020 and 2019, respectively.

Home Health Segment

|  | For the Three Months Ended September 30, |  |  |  | For the Nine Months Ended September 30, |  |
|  | 2020 |  |  |  | 2019 |  |  |  | Change |  |  |  | 2020 |  |  |  | 2019 |  |  |  | Change |  |
Home Health Segment |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % |  |  |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % of Segment Net Service Revenues |  |  |  | Amount |  |  | % |  |
|  | (Amounts in Thousands, Except Percentages) |  |  |  | (Amounts in Thousands, Except Percentages) |  |
Operating Results |  |  |  |  |  |  |  |
Net service revenues |  | $ | 4,085 |  |  |  | 100.0 |  | % |  | $ | 4,366 |  |  |  | 100.0 |  | % |  | $ | (281 | ) |  |  | (6.4 | ) | % |  | $ | 12,207 |  |  |  | 100.0 |  | % |  | $ | 10,063 |  |  |  | 100.0 |  | % |  | $ | 2,144 |  |  |  | 21.3 |  | %
Cost of services revenues |  |  | 2,685 |  |  |  | 65.7 |  |  |  |  | 2,818 |  |  |  | 64.5 |  |  |  |  | (133 | ) |  |  | (4.7 | ) |  |  |  | 8,553 |  |  |  | 70.1 |  |  |  |  | 6,803 |  |  |  | 67.6 |  |  |  |  | 1,750 |  |  |  | 25.7 |  |
Gross profit |  |  | 1,400 |  |  |  | 34.3 |  |  |  |  | 1,548 |  |  |  | 35.5 |  |  |  |  | (148 | ) |  |  | (9.6 | ) |  |  |  | 3,654 |  |  |  | 29.9 |  |  |  |  | 3,260 |  |  |  | 32.4 |  |  |  |  | 394 |  |  |  | 12.1 |  |
General and administrative expenses |  |  | 925 |  |  |  | 22.6 |  |  |  |  | 844 |  |  |  | 19.3 |  |  |  |  | 81 |  |  |  | 9.6 |  |  |  |  | 2,831 |  |  |  | 23.2 |  |  |  |  | 2,187 |  |  |  | 21.7 |  |  |  |  | 644 |  |  |  | 29.4 |  |
Segment operating income |  | $ | 475 |  |  |  | 11.6 |  | % |  | $ | 704 |  |  |  | 16.1 |  | % |  | $ | (229 | ) |  |  | (32.5 | ) | % |  | $ | 823 |  |  |  | 6.7 |  | % |  | $ | 1,073 |  |  |  | 10.7 |  | % |  | $ | (250 | ) |  |  | (23.3 | ) | %
Business Metrics (Actual Numbers) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Locations at period end |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10 |  |  |  |  |  |  |  |  | 12 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
New admissions * (1) |  |  | 1,096 |  |  |  |  |  |  |  |  | 910 |  |  |  |  |  |  |  |  | 186 |  |  |  | 20.4 |  | % |  |  | 3,186 |  |  |  |  |  |  |  |  | 2,325 |  |  |  |  |  |  |  |  | 861 |  |  |  | 37.0 |  | %
Recertifications * (2) |  |  | 607 |  |  |  |  |  |  |  |  | 764 |  |  |  |  |  |  |  |  | (157 | ) |  |  | (20.5 | ) |  |  |  | 2,006 |  |  |  |  |  |  |  |  | 1,949 |  |  |  |  |  |  |  |  | 57 |  |  |  | 2.9 |  |
Total volume * (3) |  |  | 1,703 |  |  |  |  |  |  |  |  | 1,674 |  |  |  |  |  |  |  |  | 29 |  |  |  | 1.7 |  |  |  |  | 5,192 |  |  |  |  |  |  |  |  | 4,274 |  |  |  |  |  |  |  |  | 918 |  |  |  | 21.5 |  |
Visits * (4) |  |  | 28,073 |  |  |  |  |  |  |  |  | 31,477 |  |  |  |  |  |  |  |  | (3,404 | ) |  |  | (10.8 | ) | % |  |  | 91,580 |  |  |  |  |  |  |  |  | 75,188 |  |  |  |  |  |  |  |  | 16,392 |  |  |  | 21.8 |  | %

(1) | Represents new patients during the period.

(2) | A home health certification period is an episode of care that begins with a start of care visit and continues for 60 days. If at the end of the initial episode of care, the patient continues to require home health services, a recertification is required. This represents the number of recertifications during the period.

(3) | Total volume is total admissions and total recertifications in the period.

(4) | Represents number of services to patients in the period.

* | Management deems these metrics to be key performance indicators. Management uses these metrics to monitor our performance, both in our existing operations and acquisitions. Many of these metrics serve as the basis of reported revenues and assessment of these, provide direct correlation to the results of operations from period to period and facilitate comparison with the results of our peers. Historical trends established in these metrics can be used to evaluate current operating results, identify trends affecting our business, determine the allocation of resources and assess the quality and potential variability of our cash flows and earnings. We believe they are useful to investors in evaluating and understanding our business but should not be used solely in assessing the Company’s performance. These key performance indicators should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented herein to fully evaluate and understand the business as a whole. These measures may not be comparable to similarly-titled performance indicators used by other companies.

Home health generates net service revenues by providing home health services on a short-term, intermittent or episodic basis to individuals, generally to treat an illness or injury. Net service revenues from Medicare accounted for 78.0% and 76.5%, managed care organizations accounted for 20.3% and 22.0% and other accounted for 1.7% and 1.5% for the three months ended September 30, 2020 and 2019, respectively. Net service revenues from Medicare accounted for 79.2% and 79.0%, managed care organizations accounted for 19.0% and 18.6% and other accounted for 1.8% and 2.4% for the nine months ended September 30, 2020 and 2019, respectively.

Net service revenues decreased by $0.3 million primarily due to a decrease of recertifications and visits of 20.5% and 10.8% respectively, related to COVID-19 restrictions in New Mexico. For the nine months ended September 30, 2020, net service revenues increased primarily due to an increase in total visits partially related to the acquisition of Alliance on August 1, 2019.

Gross profit, expressed as a percentage of net service revenues was 34.3% and 35.5% for the three months ended September 30, 2020 and 2019, respectively, and 29.9% and 32.4%, for the nine months ended September 30, 2020 and 2019, respectively. For the three and nine months ended September 30, 2020, the decrease of gross profit as a percentage of net service revenues was due to an increase of direct employee wages, taxes and benefit costs of 1.4% and 2.7% as a percentage of net service revenues, respectively.

The home health segment’s general and administrative expenses consist of administrative employee wages, taxes and benefit costs, rent, information technology and office expenses. General and administrative expenses, expressed as a percentage of net service revenues was 22.6% and 19.3%, respectively, for the three months ended September 30, 2020 and 2019, respectively, and 23.2% and 21.7% for the nine months ended September 30, 2020 and 2019, respectively. For the nine months ended September 30, 2020, the increase in general and administrative expenses was primarily due to increases in administrative employee wages, taxes and benefit costs of $0.6 million. The home health segment’s operating income was $0.5 million and $0.7 million for the three months ended September 30, 2020 and 2019, respectively, and $0.8 million and $1.1 million for the nine months ended September 30, 2020 and 2019, respectively.

33

Table of Contents

Liquidity and Capital Resources

Overview

Our primary sources of liquidity are cash on hand and cash from operations. At September 30, 2020 and December 31, 2019, we had cash balances of $170.3 million and $111.7 million, respectively.

During the three and nine months ended September 30, 2020, we did not draw on the term loan. As of September 30, 2020, we had a total of $43.4 million in revolving loans, with an interest rate of 1.89% and $18.4 million of term loans, with an interest rate of 1.89%, outstanding on our credit facility. After giving effect to the amount drawn on our credit facility, approximately $9.3 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA, we had $219.0 million available for borrowing under our revolving credit loan facility.

At December 31, 2019, we had a total of $43.4 million revolving credit loans, with an interest rate of 3.44%, and $18.9 million term loans, with an interest rate of 3.45%, outstanding on our credit facility. After giving effect to the amount drawn on our credit facility, approximately $10.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA, we had $191.4 million available for borrowing under our revolving credit loan facility.

Cash flows from operating activities represent the inflow of cash from our payor clients and the outflow of cash for payroll and payroll taxes, operating expenses, interest and taxes. Due to its revenue deficiencies as well as budget and financing issues, from time to time the state of Illinois has reimbursed us on a delayed basis with respect to our various agreements including with our largest payor, the Illinois Department on Aging. The open receivable balance from the Illinois Department on Aging decreased by $15.8 million from $37.6 million as of December 31, 2019 to $21.8 million as of September 30, 2020.

Amended and Restated Senior Secured Credit Facility

On October 31, 2018, we amended and restated our Existing Credit Agreement, with certain lenders and Capital One, National Association as a lender and swing line lender and as agent for all lenders. This amended and restated credit facility totals $269.6 million, inclusive of a $250.0 million revolving loan and a $19.6 million delayed draw term loan and is evidenced by the Credit Agreement. This amended and restated credit facility amended and restated our existing senior secured credit facility totaling $250.0 million. The maturity of this amended and restated credit facility is May 8, 2023, with borrowing under the delayed draw term loan available until June 30, 2019, as extended pursuant to the consent letter, dated January 30, 2019, executed by the Required Lenders (as defined in the Credit Agreement). Interest on our amended and restated credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50% and (c) the sum of the adjusted LIBOR that would be applicable to a loan with an interest period of one month advanced on the applicable day (not to be less than 0.00%) plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the offered rate per annum for similar dollar deposits for the applicable interest period that appears on Reuters Screen LIBOR01 Page (not to be less than zero). Swing loans may not be LIBOR loans. The availability of additional draws under this amended and restated credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), we can elect to increase our Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters. In connection with this amended and restated credit facility, we incurred approximately $0.9 million of debt issuance costs.

Addus HealthCare is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this amended and restated credit facility, and it is secured by a first priority security interest in all of our and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including the timely delivery of audited financial statements, limitations on us with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions and dispositions of assets.

We pay a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the amended and restated credit facility.

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement), a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum permitted amount of capital expenditures, as well as restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to us in an amount that does not exceed $7.5 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under our credit facility subject to compliance with the Total Net Leverage Ratio (as defined in the Credit Agreement), restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business.

34

Table of Contents

At September 30, 2020, we were in compliance with our financial covenants under the Credit Agreement.

Cash Flows

The following table summarizes changes in our cash flows for the nine months ended September 30, 2020 and 2019:

|  | For the Nine Months Ended September 30, |
|  | 2020 |  |  | 2019 |
|  | (Amounts in Thousands) |
Net cash provided by operating activities |  | $ | 73,299 |  |  | $ | 8,084 |
Net cash used in investing activities |  |  | (17,507 | ) |  |  | (56,301 | )
Net cash provided by financing activities |  |  | 2,825 |  |  |  | 217,420 |

Nine Months Ended September 30, 2020 Compared to Nine Months Ended September 30, 2019

Net cash provided by operating activities was $73.3 million for the nine months ended September 30, 2020, compared to $8.1 million for the same period in 2019. The increase in cash provided by operations was primarily due to decreases in accounts receivable for the state of New York, Illinois Department of Aging and a decrease in days sales outstanding (“DSO”) as discussed below, combined with organic growth and acquisition activity.

Net cash used in investing activities was $17.5 million for the nine months ended September 30, 2020 compared to cash used in investing activities of $56.3 million for the nine months ended September 30, 2019. Our investing activities for the nine months ended September 30, 2020 consisted of $6.0 million in purchases of property and equipment primarily related to investments in our technology infrastructure. Our investing activities for the nine months ended September 30, 2019 consisted of $29.9 million primarily for the acquisition of VIP, $23.5 million for the acquisition of Alliance, and $3.1 million in purchases of property and equipment primarily related to our ongoing investments in our technology infrastructure.

Net cash provided by financing activities was related to cash received from the exercise of stock options of $3.3 million for the nine months ended September 30, 2020. Our financing activities for the nine months ended September 30, 2019 were primarily related to net proceeds from our Public Offering of $172.9 million, borrowings of approximately $23.5 million on the revolver portion of our credit facility to fund the Alliance acquisition, borrowings of $19.6 million on the delayed draw term loan portion of our credit facility to fund, in part, the VIP acquisition and $2.1 million in cash received from the exercise of stock options.

Outstanding Accounts Receivable

Gross accounts receivable as of September 30, 2020 and December 31, 2019 were approximately $118.5 million and $150.6 million, respectively. Outstanding accounts receivable, net of allowance, decreased by $31.1 million as of September 30, 2020 as compared to December 31, 2019. Accounts receivable for the Illinois Department on Aging decreased approximately $15.8 million during the quarter ended September 30, 2020. Our collection procedures include review of account aging and direct contact with our payors. We have historically not used collection agencies. An uncollectible amount is written off to the allowance account after reasonable collection efforts have been exhausted. We received a bonus payment of $6.8 million in May of 2020.

We calculate our DSO by taking the trade accounts receivable outstanding, net of allowance for doubtful accounts, divided by the net service revenues for the last quarter, multiplied by the number of days in that quarter. Our DSOs were 56 days and 72 days at September 30, 2020 and December 31, 2019, respectively. The DSOs for our largest payor, the Illinois Department on Aging, at September 30, 2020 and December 31, 2019 were 48 days and 78 days, respectively. We may not receive payments on a consistent basis in the near term and our DSOs and the DSO for the Illinois Department on Aging may increase despite the state of Illinois’s enactment of state budgets for fiscal years 2020 and 2021.

The economic slowdown caused by the COVID-19 pandemic poses significant risks to states’ budgets for the 2021 fiscal year, which began July 1 in most states. Depending on the severity and length of a downturn, sales tax collections and income tax withholdings could continue to be depressed in fiscal 2021 and, potentially, future fiscal years. States could face significant fiscal challenges and may have no choice but to revise their revenue forecasts and adjust their budgets for fiscal 2021 and, potentially, future fiscal years, accordingly. In New York, which started its fiscal year April 1, the state comptroller recently estimated that the state would collect at least $10 billion less than originally forecasted, the first year-to-year cut since 2011. The current New York fiscal plan authorizes the state to issue up to $8 billion in short-term bonds to provide funds in case of reduced revenues during the fiscal year. The state issued $1.1 billion of bonds on October 28, 2020. It also allows two state authorities to provide the state with a $3 billion line of credit in the new fiscal year. As the state continues to deal with lower levels of funding due to the COVID-19 virus, the state implemented a 1% reduction to all Medicaid providers effective January 1, 2020. The recently passed budget included an additional 0.5% reduction to the Medicaid rate, which also allows the governor to make any additional changes needed as the budget year progresses.

Congress could provide additional relief with additional stimulus and relief legislation, including extension of unemployment benefits and relief for states. We cannot determine the impact that COVID-19 may have on states budgets for 2021 or beyond, however, such impacts could have a material adverse effect on our financial condition, results of operations and cash flows.

35

Table of Contents

Off-Balance Sheet Arrangements

As of September 30, 2020, we did not have any off-balance sheet guarantees or arrangements with unconsolidated entities.

Critical Accounting Policies and Estimates

There have been no material changes to our critical accounting policies and estimates previously disclosed under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Critical Accounting Policies and Estimates” set forth in Part II, Item 7 of our Annual Report on Form 10-K for the period ended December 31, 2019, filed on August 10, 2020.

Recently Issued Accounting Pronouncements

Refer to Note 2 to the Notes to Consolidated Financial Statements for further discussion.

36

Table of Contents

ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risk associated with changes in interest rates on our variable rate long-term debt. As of September 30, 2020, we had outstanding borrowings of approximately $61.8 million on our credit facility, all of such borrowings were subject to variable interest rates. If the variable rates on this debt were 100 basis points higher than the rate applicable to the borrowing during the three and nine months period ended September 30, 2020, our net income would have decreased by $0.1 million, or $0.01 per diluted share and $0.4 million, or $0.02 per diluted share, for the respective periods. We do not currently have any derivative or hedging arrangements, or other known exposures, to changes in interest rates.

ITEM 4. | CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2020. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of September 30, 2020 due to the material weaknesses in internal control over financial reporting that were disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019.

Changes in Internal Control Over Financial Reporting

During the quarter ended September 30, 2020, we continued to implement the following changes to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

| • | Implemented enhancements to the design of control activities related to the review and approval of hours worked and billed, including obtaining and reviewing the Service Organization Control 1 Type 2 (“SOC 1 Type 2”) report from our preferred electronic visit verification (“EVV”) vendor. Additionally, we enhanced existing controls to increase our level of precision of review of hours worked and billed and implemented new controls within the payroll process.

| • | Implemented enhancements to the design of control activities over the accuracy of the implicit price concession assumption used in the estimate of recoverability of unadjudicated net service revenues, including additional analysis around aged accounts receivable and using cash collection data to validate the recoverability.

Remediation Efforts with Respect to Material Weaknesses

As previously described in Part II, Item 9A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2019, our management began a remediation plan to address the material weaknesses. We have identified dedicated internal resources, supplemented with third-party specialists, to assist with formalizing a robust and detailed remediation plan and updated risk assessment, including identifying and assessing those risks commensurate with the significant changes within our company.

Because the reliability of the internal control process requires repeatable execution, the successful remediation of these material weaknesses will require review and evidence of operating effectiveness prior to concluding that the controls are effective. Although significant progress has been made, the previously identified material weaknesses continue to exist as of September 30, 2020, and will not be considered remediated until the applicable controls operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.

37

Table of Contents

PART II – OTHER INFORMATION

Item 1. | Legal Proceedings

Legal Proceedings

From time to time, we are subject to legal and/or administrative proceedings incidental to our business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on our financial position and results of operations.

Item 1A. | Risk Factors

Investing in our common stock involves a high degree of risk. You should carefully consider the risk factors discussed under the caption “Risk Factors” set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended December 31, 2019, as filed on August 10, 2020. There have been no material changes to the risk factors previously disclosed under the caption “Risk Factors” in our Annual Report on Form 10-K. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or operating results.

Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. | Defaults Upon Senior Securities

None.

Item 4. | Mine Safety Disclosures

None.

Item 5. | Other Information

None.

38

Table of Contents

Item 6. | Exhibits

3.1 |  | Amended and Restated Certificate of Incorporation of the Company dated as of October 27, 2009 (filed on November 20, 2009 as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q (File No. 001-34504) and incorporated by reference herein).
3.2 |  | Amended and Restated Bylaws of the Company, as amended by the First Amendment to the Amended and Restated Bylaws (filed on May 9, 2013 as Exhibit 3.2 to the Company’s Quarterly Report on Form 10-Q (File No. 001-34504) and incorporated by reference herein).
4.1 |  | Form of Common Stock Certificate (filed on October 2, 2009 as Exhibit 4.1 to Amendment No. 4 to the Company’s Registration Statement on Form S-1 (File No. 333-160634) and incorporated by reference herein).
31.1 |  | Certification of Chief Executive Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 |  | Certification of Chief Financial Officer Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934 as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 |  | Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 |  | Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS |  | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH |  | Inline XBRL Taxonomy Extension Schema Document.
101.CAL |  | Inline XBRL Taxonomy Calculation Linkbase Document.
101.LAB |  | Inline XBRL Taxonomy Label Linkbase Document.
101.PRE |  | Inline XBRL Presentation Linkbase Document.
101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document.
104 |  | Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101).

* | Management compensatory plan or arrangement

39

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  | ADDUS HOMECARE CORPORATION
Date: November 6, 2020 |  | By: |  | /s/ R. DIRK ALLISON
|  |  |  | R. Dirk Allison President and Chief Executive Officer (As Principal Executive Officer)
Date: November 6, 2020 |  | By: |  | /s/ BRIAN POFF
|  |  |  | Brian Poff Chief Financial Officer (As Principal Financial Officer)

40